WPIDS / WPINDEX / WPIX (Derwent World Patents Index®)
WPIDS
Derwent World Patents Index® Subscriber File
WPINDEX
Derwent World Patents Index® Standard File
WPIX
Derwent World Patents Index® Subscriber File with Extension Abstract
Access to WPIDS and WPIX is subject to a relevant subscription with Clarivate (UK) Limited

Subject
Coverage

All patent-relevant areas of science and technology. The start of coverage varies by bothsubject matter and patent authority:• Pharmaceuticals: 1963
• Plastics and polymers: 1966
• Mechanical, electrical, and general technology: 1974
• Agricultural chemicals: 1965
• All other chemistry and general technology: 1970

File Type

Bibliographic

Features

ThesauriEuropean Patent Classification (/EPC), F-Term (/FTERM), FI-Term(/FCL), ICO (in-computer-only) Classification (/ICO), International
Patent Classification (/IPC), Cooperative Patent Classification (/CPC),
Manual Code (/MC), Polymer Indexing Enhanced (/PLE), Title Terms(/TT), and US National Patent Classification (/NCL). There is athesaurus-like feature in the Compound Number (/DCN), Registry
Number (/DRN), Patent Assignee Code (/PACO), and Plasdoc Key
Serials (/KS)

Alerts (SDIs)

Monthly, weekly, or with each update (2 updates per week)(every update is the default)

CAS Registry
Number®
Identifiers



SLART



Keep & Share

Structures



RecordContent

Bibliographic Records• Patent family data available for each bibliographic record (Derwent patent family):- Basic patent- Equivalents (information about the same invention issued in other countries)• Invention Level: bibliographic data and Derwent value-added titles, abstracts, generaland (where appropriate) in-depth chemical and electrical indexing. Electrical,
engineering drawings and chemical structure drawings. Data from the individual
member patents is collated and de-duplicated.
• Member Patent Level (Publication Level): bibliographic data, equivalent abstracts andgeneral indexing information associated with individual documents in the patent family.
Additional first-level elements comprise author titles and abstracts, claims, original
inventor, patent assignee and agent information including addresses.
• Claims information is available for more than 20 patent authorities.
• The Derwent Patents Citation® Index is fully integrated in DWPI, covering backward
and forward patent citations, as well as literature citations of 32 patent authorities.
• Certain features are restricted to eligible users holding an appropriate subscription.
WPIDS users with the appropriate level of subscription are entitled to search for
special indexing like chemical, polymer coding, or chemical manual codes. WPIX
subscribers can also access display of abstract extensions, and documentation
abstracts.
• Numeric values of 59 physical and chemical properties in more than 20,000 unit
variants are searchable in all English text fields (titles, abstracts, claims).

February 2024

2
WPIDS / WPINDEX / WPIX

File Size• More than 58 million records with more than 46 million images (02/2023)

Coverage• 1963-present• Electrical and engineering drawings: 1988-present• Chemical structure drawings 1988-present

Updates

Updated twice a week with about 47,000 new records (Basic Patents), about 66,000
Equivalents, Polymer and Chemical Coding, and about 43,000 images (technicaldrawings and chemical structure drawings)

Language

English

Database
Producer

Clarivate
Friars House
160 Blackfriars Rd.
London SE1 8EZ
United Kingdom
Copyright Holder: Clarivate

Sources

Patent documents are covered from 59
patent authorities:
Argentina (1975)
Armenia (2002-present)
Australia (1963-69,1983-pres.)
Austria (1975-present)
Belarus (2002-present)
Belgium (1963-present)
Brazil (1976-present)
Canada (1963-present)
China (1987-present)
Czech Republic (1994-present)
Czechoslovakia (1975-1994)
Denmark (1974-present)
Eurasian Patent Organization (2002-present)
European Patent Office (1978-present)
Finland (1974-present)
France (1963-present)
Georgia (2002-present)
Germany (1963-present)
Germany (Utility Models) (1995-present)
German (Dem. Rep.) (1963-1990)
Gulf Cooperation Council (2011-present)
Hong Kong (2011-present)
Hungary (1975-present)
India (2004-present)
Indonesia (2010-present)
Ireland (1963-69,1995-pres.)
Israel (1975-present)
Italy (1966-69,1978-present)
Japan (1963-present)

Kazakhstan (2002-present)
Kyrgyzstan (2002-present)
Luxembourg (1984-present)
Malaysia (2005-present)
Mexico (1997-present)
Moldova (2002-present)
Netherlands (1963-present)
New Zealand (1993-present)
Norway (1974-present)
PCT (WIPO) (1978-present)
Philippines (1994-present)
Poland (2011-present)
Portugal (1974-present)
Rep. of Korea (1986-present)
Romania (1975-present)
Russian Federation (1994-present)
Singapore (1995-present)
Slovakia (1994-present)
South Africa (1963-present)
Soviet Union (1963-1994)
Spain (1983-present)
Sweden (1974-present)
Switzerland (1963-present)
Taiwan (1993-present)
Tajikistan (2002-present)
Thailand (2010-present)
Turkey (2015-present)
United Kingdom (1963-present)
United States (1963-present)
Uzbekistan (2002-present)
Vietnam (2010-present)

Additional Sources are:
- Research Disclosure (1978-present)- International Technology Disclosures (1984-93)

Comprehensive details of coverage within Derwent World Patents Index® can be foundwithin the DWPI reference center at the Clarivate home page:https://clarivate.com/products/dwpi-reference-center/dwpi-coverage/
February 2024

3
WPIDS / WPINDEX / WPIX

Sources(cont.)The Derwent Patents Citation® Index is fully integrated in DWPI, covering backward andforward patent citations, as well as literature citations of 32 patent authorities.
Additional first level data elements such as original titles and abstracts, claims, inventor,
assignee and agent information and addresses may be present at the Member Patent
Level as follows:
https://www.stn-international.com/en/training-center/recorded-e-seminars/derwent-worldpatents-index-database-stn-overview-value-added
Claims information is available for more than 20 patent authorities. See HELP CLAIMS in
the database for details.
•
•
•
•
•
•
•
•
•
•

User Aids

Derwent World Patents Index® STN Online User Guide
STNGUIDE
Online Helps (HELP DIRECTORY lists all help messages available)
Patent Sources *Derwent Patents Citation® Index, STN Reference Manual **Introduction to Chemical Indexing
Classification User Guide *Title Terms User Guide *Patentee Codes User Guide *CPI Chemical Indexing Guidelines, Indexing of Chemical and Pharmaceutical
Patents *• CPI Chemical Indexing User Guide *• CPI Manual Codes User Guide *• Chemistry Resource on STN *• CPI Plasdoc Coding Systems User Guide *• Polymer Indexing Directory Parts 1 and 2 *• Polymer Indexing Reference Manual *• Polymer Indexing System Description User Guide *• Polymer Indexing Thesaurus Guide *• Polymer Indexing Hierarchy User Guide *• EPI Manual Codes User Guide Parts 1, 2 and 3 ** Available from the producer, see also DWPI reference center:
https://clarivate.com/derwent/dwpi-reference-center/** Available from the training center of the STN home page:https://www.stn-international.com/en/training-center

Cluster

•
•
•
•
•
•

AEROTECH
ALLBIBAUTHORS
BIOSCIENCECORPSOURCEENGINEERING

•
•
•
•
•

FORMULATIONSHPATENTSNPSPATENTSPOLYMERSSTN Database Cluster information:
https://www.cas.org/support/training/stn/database-clusters

RelatedDatabases••

DWPIM – Derwent Markush structure database includes all generic compounds
which have been indexed in the corresponding DWPI database
DCR – Derwent Chemistry Resource structure database includes specificcompounds which have been indexed in the corresponding DWPI database

February 2024

4
WPIDS / WPINDEX / WPIXDWPI Invention Level
Search Fields
Fields that allow left truncation are indicated by an asterisk (*).

SearchCode

Search Field Name

Display
Codes

Search Examples

Basic Index* (contains single
words from AB, ABDT, ABEQ,
ABEX, ACTN, ACTV, ADV,
ALE, DETD, DRWD, NOV,TECH, TI, TT, UADV, and USE)
(18)

None
or
/BI
(or /BIX)S DRILLING FLUID AND EMULS?
S ?PHENYLETHER?
S #####DIPHENYLETHERS ULCER TREATMENT(L)ORAL

AB, ABDT,ABEQ, ABEX,
ACTN, ACTV,
ADV, ALE,
DETD, DRWD,
NOV, TECH,
TI, TT, UADV,
USE

Abstract *(contains value-addeddata) (18)
Abstract, Documentation * (1,18)
Abstract, Documentation Type,
Activity *(1,18)
Abstract, Documentation Type,
Administration *(1,18)
Abstract, Documentation Type,
Advantage *(1,18)
Abstract, Documentation Type,
Biology *(1,18)
Abstract, Documentation Type,
Claimed *(1,18)
Abstract, Documentation Type,Definition *(1,18)
Abstract, Documentation Type,
Description *(1,18)
Abstract, Documentation Type,
Dosage *(1,18)
Abstract, Documentation Type,Drawing Description *(1,18)
Abstract, Documentation Type,
Embodiment *(1,18)
Abstract, Documentation Type,
Example *(1,18)
Abstract, Documentation Type,First Section *(1,18)
Abstract, Documentation Type,
General *(1,18)
Abstract, Documentation Type,
Inorganic Chemistry *(1,18)
Abstract, Documentation Type,
Mechanism of Action *(1,18)
Abstract, Documentation Type,
More Specifically *(1,18)
Abstract, Documentation Type,
Novelty *(1,18)
Abstract, Documentation Type,
Organic Chemistry *(1,18)
Abstract, Documentation Type,Specific Materials *(1,18)/AB

S OSTEOGENIC PROTEIN?/AB

AB

/ABDT
/ABDT.ACTV

S (DNA AND PROTEIN)/ABDTS AGONIST?/ABDT.ACTV

ABDT
ABDT

/ABDT.ADM

S ORAL/ABDT.ADM

ABDT/ABDT.ADV

ABDT/ABDT.BIO

S (STRENGTH AND (INCREAS? OR RIS?
OR GAIN?))/ABDT.ADV
S (LEUKAEM? AND CELL?)/ABDT.BIO/ABDT.CLM

S KETON?/ABDT.CLM

ABDT/ABDT.DEF

S CYCL?/ABDT.DEF

ABDT/ABDT.DESS ARYL?/ABDT.DES

ABDT/ABDT.DOS

ABDT/ABDT.DRWD

S (SPRAY? OR AEROSOL OR DUST? OR
POWDER? OR GRANUL?)/ABDT.DOS
S FILTER?/ABDT.DRWD/ABDT.EMB

S (POLYESTER AND RESIN?)/ABDT.EMB

ABDT/ABDT.EXS BIODEGRAD?/ABDT.EX

ABDT/ABDT.FSS NYLON/ABDT.FS

ABDT/ABDT.GENS RARE EARTH/ABDT.GEN

ABDT/ABDT.INO

S (FIBER OR RESIN)/ABDT.INO

ABDT/ABDT.ACTNS CELL?/ABDT.ACTN

ABDT/ABDT.MS

S (F OR Cl)/ABDT.MS

ABDT/ABDT.NOVS (SHEET OR FABRIC)/ABDT.NOV

ABDT/ABDT.ORGS TETRAHYDROFURAN/ABDT.ORG

ABDT/ABDT.MATS VINYL?/ABDT.MAT

ABDT

ABDT

ABDT

February 2024

5
WPIDS / WPINDEX / WPIXDWPI Invention Level
Search Fields (cont’d)SearchCode

Search Examples

Abstract, Documentation Type,
Preferred *(1,18)
Abstract, Documentation Type,
Preparation *(1,18)
Abstract, Documentation Type,Specific Substances *(1,18)
Abstract, Documentation Type,Technology Focus *(1,18)
Abstract, Documentation Type,Use *(1,18)
Abstract, Documentation Type,
Use/Advantage *(1,18)
Abstract, Documentation Type,
Wider Disclosure *(1,18)
Abstract, Extension * (2,18)
Abstract, Ext., Administration * (2)Abstract, Ext., Definition * (2)Abstract, Ext., Example * (2)Abstract, Ext., Priority * (2)Abstract, Ext., SpecificCompounds * (2)Abstract, Ext., Wider Disclosure *(2)
Accession Number/ABDT.PRES BUTYROLACTON?/ABDT.PRE

ABDT/ABDT.PRPS IMIDAZOL?/ABDT.PRP

ABDT/ABDT.SUB

S MALEIC/ABDT.SUB

ABDT/ABDT.TECH

S (LAYER? OR COAT?)/ABDT.TECH

ABDT/ABDT.USE

ABDT/ABDT.UADV

S ((DERM? OR SKIN?) AND
AGE?)/ABDT.USE
S (TAST? OR EAT?)/ABDT.UADV/ABDT.WDS BLOOD?/ABDT.WD

ABDT

/ABEX
/ABEX.ADM/ABEX.DEF/ABEX.EX/ABEX.PRI/ABEX.SCS ?FERMENT?/ABEXS BUCCAL(P)DOS?/ABEX.ADM
S (?ALKYL? AND ?ALKOX?)/ABEX.DEF
S (NUC? AND COMPLEX?)/ABEX.EXS METABOLIC/ABEX.PRIS ?NITRO?/ABEX.SC

ABEX
ABEX
ABEX
ABEX
ABEX
ABEX

/ABEX.WDS KINASE?/ABEX.WD

ABEX

/AN

AN

Accession Number Week,
Supplement
Activity * (18)
Advantage * (18)
Alerting Abstract, First Section *(18)
Application Country (3)Application Country, Basic
Application Date (3,4)
Application Date, Basic (3,4)
Application Number (3,5)
Application Number, Basic (3,5)
Application Number, Year (4)Application Type
Application Year (3,4)
Application Year, Basic (3,4)
Chemical Codes (19,22)
Chemical Resource Number/DW.ANS 2008-B12345/AN
S 2007-894520/AN
S 197022/DW.AN

/ACTV
/ADV
/ALE

S ANTIBIOTIC ACTIVITY/ACTVS LASER BEAM?/ADV
S (CATALY?(2A)REDUC?)/ALE

AB, ACTV
AB, ADVALE, ABS

/AC
/AC.B
/AD
/AD.B
/AP
/AP.B
/AP.YR
/APT
/AY
/AY.B
/M0 - /M6
/DCR

ADT, AIHITMEMB
ADT, AIHITMEMB
ADT, AIHITMEMB
ADT, AI
ADT, AI
ADT, AIHITMEMBCMC
IT, CMC

Chemical Resource Number,
Unlinked
Cooperative Patent Classification
Country Count (4)CPC, Action Date (4)CPC, Codes of a Combination Set/DCRU

S GB/AC(P)1990/AY
S AU/AC.B
S JAN 1993-APR 1993/AD(P)FR/ACS US/AC.B(P)OCT 2015/AD.B
S GB1989-219641/AP
S KR2019-100030/AP.B
S 2004/AP.YR
S RELATED TO/APTS 1990-1991/AY
S 2017-2020/AY.B
S ((D711(P)F431(P)H522)/M2,M3,M4
S DCR-1911/DCR
S 1911/DCR
S DCR-1/DCRU

/CPC
/CYC
/CPC.ACD/CPC.CSS D03D0015-0011/CPC
S 20-30/CYC
S 20130101/CPC.ACD
S A61K0039-42/CPC.CS

CPC, Keyword Terms
CPC, Version
Cross Reference/CPC.KW/CPC.VER/CR(or /XR)/ANXS INVENTION/CPC.KW
S 20130101/CPC.VER
S 1990-001459/CR
S 1990-001459/AN,CR

CPC
CYC
CPC.TABCPC,
CPC.TAB
CPC.TAB
CPC.TABCR

Search Field Name

Crossover Accession Number

S 1980-B7362C/ANX

Display
Codes

ABDT

AN

DCRU, CMC

ANX

February 2024

6
WPIDS / WPINDEX / WPIXDWPI Invention Level
Search Fields (cont’d)SearchCode

Search Field Name
Designated State (6)/DS

Detailed Description* (18)Document Level
Document Number CPI
Document Number Non CPI
Document TypeDrawing Description* (18)DWPI Class (7)

/DETD
/DLVL
/DNC
/DNN
/DT
/DRWD
/DC

DWPI Compound Number/DCN

DWPI Registry Number (22)/DRN

DWPI Update (formerly Derwent
Week) (4,6)
DWPI Update (formerly Derwent
Week), first and latest (4)DWPI Update, Basic (formerly
Derwent Week, Basic) (4,6)
Entry Date (4)European Patent Classification (8)/DW

Display
Codes

Search Examples
PI

/DUPD

S BE/DSS RW: BE/DS(P)1990/PY
S NAPHTHALENE?/DETD
S L1 AND INVENTION/DLVLS C1993-056092/DNC
S N1983-041955/DNN
S L7 AND P/DT
S ?TANGUL?/DRWD
S A25/DCS A/DCS DCN-R00001/DCN
S R00001/DCN
S DRN-0001/DRN
S 0001/DRN
S 199108/DW
S 199301-199315/DW(P)FR/PC
S 197007/DUPD/DW.B

S 199315/DW.B(P)US/PC.B

PI, PI.B

S ED>19940201 AND L10
S A01B0015-20/EPC

ED
EPC

Field Availability

/ED
/EPC
(or /ECLA,or /EPCLA)/FA

FA

File Segment
Filing Details (5,6)

/FS
/FDT

Filing Details, Patent Country(WIPO code and text)
Filing Details, Patent Kind

/FDT.PC(or /RLPC)/FDT.PK(or /RLPK)/FDT.PN(or /RLPN)/FDT.TP/FG(or /AM)/ICO

S L7 NOT NOAB/FA
S L11 AND GI/FAS PLASMA AND EPI/FSS US5072794/FDT
S EP105613/FDTS CANADA/FDT.PC
S CA/FDT.PC
S CAA/FDT.PK
S CA1248729/FDT.PN

FDT

S REISSUE OF/FDT.TP
S (012(P)032(P)046)/FG

FDT
FG, PLCS K61M/ICO

ICO
IT

/IN
(or /AU)/IPC.ACD/ICAS DCR-168/IT
S 168/ITS C12P0021-08/IPC
S C12P0021/IPC
S C12P/IPC
S HALE, A H/INS HALE A H/IN,PA
S IPC.ACD>20070107
S A01K067-027/ICA/IPC.F/ICIS A61K0008-63/IPC.F
S B03D0103:04/ICI

HIT, IPC.TAB
ICIFiling Details, Patent Number
Filing Details, Type
Fragmentation Code (PLASDOC)(19, 20, 22)
ICO (in-computer-only)
Classification (8)Index Term
International Patent Classification(all versions (1-8): ICA, ICI,
ICM, ICS, IPC.REF) (8)Inventor
IPC, Action Date (4)IPC, Additional (supplementary,
IPC 1-7))
IPC, First
IPC, Index (complementary, IPC
1-7)

February 2024/IT(or /KW)/IPC

AB, DETD
not displayed
DNC, DN
DNN, DN
not displayed
AB, DRWD
DC
DCN
DRN
PI
DUPD

FS
FDT
FDT
FDT

IPC

IN
IPC.TABICA

7WPIDS / WPINDEX / WPIXDWPI Invention Level
Search Fields (cont’d)SearchCode

Search Field Name

Display
Codes

Search Examples

IPC, Keyword Terms
IPC, Main (IPC1-7)
IPC, Reform/IPC.KW/ICM/IPC.REF

S ADDITIONAL/IPC.KW
S C09K007-02/ICM
S A01B0003-44/IPC.REF

IPC, Secondary (IPC 1-7)
IPC, Version (4)IPC, Main and Secondary (IPC 17)
Japanese Patent Classification(FI-Terms, secondary)
Japanese Patent Classification(FI-Terms)
Japanese Patent Classification(FI-Terms, additional)
Japanese Patent Classification(FI-Terms, index)
Japanese Patent Classification(FI-Terms, main)
Japanese Patent Classification(F-terms) (8)/ICS/IPC.VER/ICS D01B001-38/ICS
S 20080101/IPC.VER
S C09K0007-02/IC

IPC.TABIC, IPC
IPCI, IPCR,
IPC
IC, IPC
IPC.TABIC, IPC/FSCL

S H05K0013-08 Z/FSCL

FCL

/FCL

FCL

/FACL

S C12N0001-00 A/FCLS A23L0033-135/FCL(T)ZNA/FCLS A01B0069-00 303 Z/FACL/FICL

S A61K0035-12/FICL

FCL

/FMCL

S H01B0001-02/FMCL

FCL

/FTRM
(or /FTERM, or/FTCLA, or/JPCLA)/LAS 5B001/AA01/FTRM
S (4F100(T)DC11)/FTRM

FTRM

S FR/LA(P)EP/PC AND L3
S FRENCH/LA(P)EP/PC(P)1990/PY
S A12-W10A/MC
S 0153-12201-CL/MCN
S KINASE INHIBITOR?/ACTN
S EXCITATION LIGHT/NOVS DRWN=9S PGN=5 AND L2
S SHELL OIL/PA
S "NEW YORK WIRE"?/PA
S SHEL/PACOS GB/PC(P)1989/AY
S UNITED KINGDOM/PC
S GB/PC.B(P)JUNE 1992/PD.B
S GBA/PKS EPA2/PK(P)DE/DS
S EPA/PK.B
S EPA1/PK.B(P)1991-1992/PY.B
S US5198416/PN
S EP100323/PN
S US20060000001/PN
S US,100,503/PN
S WO99/9/PN
S JP6905629B/PN
S US5198416/PN.B
S 5-10/PNC
S WO2009006253A2/PNK
S TH43458A/PNK.B
S EQUIVALENT/PT AND BE/PC
S 0004 0003/KS
S (R01737(P)C088)/PLE

PI

Language (ISO code and text)
Manual Code (8,9,23)
Markush Compound Number
Mechanism of Action *Novelty* (11,18)
Number of Drawings (4)Number of Pages (4)Patent Assignee (10)Patent Assignee Code (8,12)
Patent Country (6,13)

/MC
/MCN
/ACTN
/NOV
/DRWN
/PGN
/PA
(or /CS)/PACO/PC

Patent Country, Basic (6,13)
Patent Kind Code (6,14)

/PC.B
/PK

Patent Kind Code, Basic (6,14)/PK.B

Patent Number (5,6)/PN

Patent Number, Basic (5,6)
Patent Number Count (4)Patent Number/Kind CodePatent Number/Kind Code, Basic
Patent Publication Type
Plasdoc Key Serials (19,20,21,22)
Polymer Indexing Enhanced(21,22)

/PN.B
/PNC
/PNK
/PNK.B
/PT
/KS
/PLE

FCL

MC
MCN, CMC
AB, ACTN
NOV
DRWN
PI
PA
PA
PI
PI
PI

PI, PN

PI
PNC
PNK
PNK.B
PI, PN
KS, PLC
PLE

February 2024

8
WPIDS / WPINDEX / WPIXDWPI Invention Level
Search Fields (cont’d)Search Field Name

SearchCodePriority Country (15)/PRC

Priority Country, First
Priority Date (4,15)

/PRCF
/PRD

Priority Date, First (4,15)
Priority Number (5,15)

/PRDF
/PRN

Priority Number, First
Priority Number, Year (4)Priority Year (4,15)
Priority Year, First (4,15)
Publication Date (4,6)/PRNF/PRN.YR
/PRY
/PRYF
/PD

Publication Date, Basic (4,6)
Publication Year (4,6)
Publication Year, Basic (4,6)
Ring Index Number (22)

/PD.B
/PY
/PY.B
/RIN

Ring Index Number, Unlinked (22)

/RINU

Role (20)Technology* (11,18)
Title* (18)
Title Terms * (16,18)(incl. Additional Words)
Update Date (4)Update Date Abstract (4)Update Date Chemical Code(4,22)
Update Date Cooperative PatentClassification
Update Date Enhanced Title (4)Update Date Index Term (4)

/RL
/TECH
/TI
/TT

Update Date International PatentClassification (4)Update Date Inventor (4)Update Date Japanese PatentClassification (4)Update Date Manual Code (4)Update Date Patent Assignee(4,22)
Update Date Patent Family (4)Update Date Polymer Indexing (4)US National Patent Classification,
Current (8)US National Patent Classification,
Current (main)
US National Patent Classification,
Current (secondary)
Use Section* (18)Use/Advantage Section * (18)

February 2024

Search Examples

Display
Codes
PRAI

/UP
/UPAB
/UPB

S FR/PRC
S GB/PRC(P)1990/PRY
S AU/PRCF
S 19880930/PRD
S JUNE 1991/PRD(P)FR/PRC
S JUNE 1991/PRDF
S 1988US-000252206/PRN
S US1988-252206/PRN
S 1990DE-0000010670/PRN
S DE1990-10670/PRN
S AL1961-8036/PRNF
S 2005/PRN.YR
S 1990-1991/PRY(P)NL/PRC
S 1992/PRYF
S 19900404/PD
S 1 APR 1990-15 APR 1990/PD(P)GB/PC
S 19930330/PD.B(P)US/PC.B
S 1990-1991/PY
S 1990/PY.B(P)JP/PC.B
S RIN-00012/RIN
S 00012/RIN
S 00044/RINU
S RIN-00044/RINUS DCR-1/DCR(T)(P OR PRD)/RL
S DYEING AGENT#/TECH,BIS DRILLING FLUID#/TI
S DRILL/TT
S FIBRE-OPTIC/TTS JAN 2007/UP
S FEB 2009/UPAB
S UPB=APR 2005

/UPCP

S JAN 2021-JUNE 2021/UPCP

UPCP

/UPTI
/UPIT
(or /UPKW)/UPIC

S 20050422/UPTI AND L2
S 20050412/UPIT

UPTI
UPIT

S 20090918/UPIC

UPIC

/UPIN
/UPFT

S UPIN=3 MAY 2013
S UPFT>20210601

UPIN
UPFT

/UPMC
/UPPA

S 2021/UPMC
S 20050426/UPPA AND L15

UPMC
UPPA

/UPP
/UPA
/NCL

S FEB 1994-APR 1994/UPPS UPA=APR 2005
S 002006100/NCL

UPP
UPA
NCL

/NCLM

S 002/NCLM

NCL

/NCLS

S 004/NCLS

NCL

/USE

S (SYNTHESIS AND BIOSYNTHETIC)/ USE
S ?PHENYLETHER?/USE
S ?TREATMENT?/UADV

USE

/UADV

PRAI
PRAI
PRAI
PRAI

PRAI
PRAI
PRAI
PRAI
PI
PI
PI
PI
RIN, CMC
RINU, RIN,
CMC
IT, CMC
TECH
TI
TT
UP
UPA
UPB

UADV

9
WPIDS / WPINDEX / WPIX
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)

This field is displayable in WPIX only. Available for 1995-1999.
This field is displayable in WPIX only. Available from update 199908 onwards.
Application Information is linked by (P) proximity to the patent information of the respective document.
Numeric search field that may be searched using numeric operators or ranges.
Numbers are searchable in DWPI and STN format.
Patent information (PN, PC, PK only) and application information of one patent document is linked by (P) proximity.
The classification text of DWPI classes is available in abbreviated form for EXPAND, however not for SEARCH
A thesaurus is available in this field.
DWPI manual codes automatically echo each search term and its definition when you search.
Search with implied (S) proximity is available in this field. Bound phrases have to be searched with quotation marks.
Available from Update 199908 onwards.
The list of Clarivate (UK) Limited-assigned company codes for patent assignees matched with company names
is available in this field. See page 18.
Enter HELP COUNTRY online for detailed coverage information.
Enter HELP KIND online for definitions of the patent document kind codes.
Priority information referring to the same application is linked by (P) proximity.
RL includes roles for DCR-, MCN-, DRN- and DCN-numbers, search numbers and roles with (T)-proximity
A function for preferred and forbidden terms (USE, UF relationship) is available for EXPAND and SEARCH in this field – see 'DWPI
Title Terms' on page 18. By default, the preferred term is searched, when a forbidden one is part of the query.
The words AND, IS, OF, THE, and TO are not indexed in this field.
You may use these stop words in your search statement, however at their position a (1W)-proximity is used by the system.
Search with implied (P) proximity is available in this field.
Fields /FG and /KS were discontinued as of DWPI update 199401 being replaced by field /PLE.
/PLE is available since DWPI update 199332, replacing fields /FG and /KS. There are three levels of linking in thisfield: tightest – (S), middle – (P), widest – (L) proximity. The Polymer Indexing Thesaurus is available online in /PL.
Field available in subscriber files WPIDS/WPIX only.
Manual codes of sections A-N are available in the subscriber files WPIDS/WPIX only.

Super Search Fields
Enter a super search code to execute a search in one or more fields that may contain the desired information.
Super search fields facilitate crossfile and multifile searching. EXPAND may not be used with super search
fields. Use EXPAND with the individual field codes instead.
Search Field Name

SearchCode

FieldsSearched

Application Number Group (1)/APPS/AP, /PRN

Document Number
Chemical Codes, all Subfields

/DN
/MALL

Patent Number Group/PATS/DNC, /DNN
/M0, /M1, /M2,
/M3, /M4, /M5,
/M6
/PN, /FDT.PN

Patent Countries/PCS/PC, /DS

Search Examples

DisplayCodes

S 1989GB-0219641/APPS
S 1989GB-0219641/APPSS C1993-056092/DN
S A100/M2

ADT, AI,PRAI
DNC, DNN
M2, CMCS GB2223255/PATS
S EP------100323/PATSS EP100323/PATS
S ES/PCSS SPAIN/PCS

FDT, PI

DS, PI, PN(1) Either STN or Derwent format may be used.

February 2024

10
WPIDS / WPINDEX / WPIX

Additional DWPI Individual Patent Publication (often First Level Data)
Search Fields
Fields that allow left truncation are indicated by an asterisk (*).
Search Field Name

SearchCode

Search Examples

Display
Codes

Basic Index Extended* (contains single
terms from author abstracts, claims,
and original titles) (2)/BIEX

S NANOCLUSTERS/BIEX

ABDE, ABEN,
ABES, ABFR,
ABOL, CLMDE,
CLMEN, CLMES,CLMFR, CLMOL,
TIDE, TIEN, TIES,TIFR, TIOL

Abstract, Original, in English* (2)Abstract, Original, in French* (2)Abstract, Original, in German* (2)Abstract, Original, in other Language*(2)
Abstract, Original, in Spanish* (2)Agent (3)Agent Address (3)Agent, City
Agent, Country (code)
Agent, Postal CodeAgent, State
Agent, Total (3)Application Information, Clarivate
Claims (all languages)* (2)

/ABEN
/ABFR
/ABDE
/ABOL

S ?CONDUCTIVE MATERIAL/ABEN
S ?MOBILIS?/ABFR
S ?AUTOMATISIERT?/ABDES CATALISADOR/ABOL

ABEN
ABFR
ABDE
ABOL

/ABES
/AG
/AGA
/AG.CTY/AG.CNY/AG.ZIP/AG.ST
/AG.T
/APTS
/CLM

Claims in English (2)Claims in French (2)Claims in German (2)Claims in other Languages (2)Claims in Spanish (2)Field Availability (Individual Members)
Inventor Address (3)Inventor, City
Inventor, Country
Inventor, Nationality (WIPO Code)Inventor, Original
Inventor, Postal CodeInventor, Residence (WIPO Code)Inventor, State
Inventor, Surname
Inventor, Total (3)IPC, Initial (IICM, IICS)
IPC, Initial, Additional (supplementary)
IPC, Initial, Index (complementary)
IPC, Initial, Main
IPC, Initial, Secondary
Patent Assignee Address (3)Patent Assignee, City
Patent Assignee, Country
Patent Assignee, Limitation (WIPO
code)/CLMEN/CLMFR/CLMDE/CLMOL/CLMES/FA.M/INA/IN.CTY/IN.CNY/IN.NAT/INO/IN.ZIP/IN.RES/IN.ST/INO.SNM
/IN.T
/IIC
/IICA
/IICI
/IICM
/IICS
/PAA
/PA.CTY/PA.CNY/PA.LIMS (METODO(2A)SINTESIS)/ABESS PFIZER/AGS NEWCASTLE/AGA
S (MUNICH OR MUENCHEN)/AG.CTY
S NL/AG.CNY
S 69134/AG.ZIP
S NY/AG.ST
S PFIZER INC./AG.T
S 1978US-000000357/APTS
S OFFICE CHAIR/CLM
S BUEROSTUHL/CLM
S ?CHAIR?/CLM
S (CATALY?(2A)?REDUC?)/CLMENS (CATALYS?(2A)MICROP?)/CLMFRS KATALYSATORSYSTEM?/CLMDE
S (EMULSAO(P)OLEO)/CLMOLS (METODO(5A)CUALQUIERA)/CLMESS CLMEN/FA.M
S HEIDELBERG/INA
S WIEN/IN.CTY
S DE/IN.CNY
S AT/IN.NAT
S MAYER DALE J/INO
S 69469/IN.ZIP
S BE/IN.RES
S OH/IN.ST
S SCHEKINEN/INO.SNM
S MAYER?/IN.T
S A01B000/IIC
S A01B003-36/IICA
S B03D0103:08/IICIS C09K007-02/IICM
S A01B001/IICS
S MUENCHEN?/PAAS MUNICH/PA.CTY
S BE/PA.CNY
S DE/PA.LIM

ABES
AG
AGA
AGA
AGA
AGA
AGA
AG.T
APTS
CLMDE, CLMEN,
CLMES, CLMFR,
CLMOL
CLMEN
CLMFR
CLMDE
CLMOL
CLMES
FA.M
INA
INA
INA
INA
INO
INA
INA
INA
INO
IN.T
IIC
IICA
IICI
IIC
IIC
PAA
PAA
PAA
HITMEMB

February 2024

11
WPIDS / WPINDEX / WPIX

Additional DWPI Individual Patent Publication (often First Level Data)
Search Fields (cont’d)Search Field Name

SearchCode

Display
Codes

Search Examples

Patent Assignee, Nationality (WIPO
code)
Patent Assignee, Original (3)Patent Assignee, Postal CodePatent Assignee, Residence (WIPO
code)/PA.NATS BE/PA.NAT

HITMEMB/PAO/PA.ZIP/PA.RES

S 3M COMPANY/PAO
S 69140/PA.ZIP
S DE/PA.RES

PAOPAAHITMEMB

Patent Assignee, State
Patent Assignee, Total (3)Priority Application Information,
Clarivate
Priority Country, Basic (WIPO codeand text)
Priority Date, Basic (1)Priority Number, BasicPriority Year, Basic (1)Title, Original, in English* (2)Title, Original, in French* (2)Title, Original, in German* (2)Title, Original, in other Languages * (2)Title, Original, in Spanish* (2)Update Date Agent (1)Update Date Author Abstract (1)Update Date Author Title (1)Update Date Claims (1)US National Patent Classification,
IssuedUS National Patent Classification,
Issued (main)
US National Patent Classification,
Issued (secondary)/PA.ST/PA.T/PRTS

S OH/PA.ST
S BASF AG/PA.T
S 2021WO-CA0050007/PRTS

PAA
PA.T
PRTS

/PRC.BS AR/PRC.B

PRAI/PRD.B/PRN.B/PRY.B
/TIEN
/TIFR
/TIDE
/TIOL
/TIES
/UPAG
/UPAA
/UPAT
/UPCL
/INCL

PRAI
PRAI
PRAI
TIEN
TIFR
TIDE
TIOL
TIES
UPAG
UPAA
UPAT
UPCL
INCL

/INCLM

S PRD.B=JUN 1998
S AR1968-214388/PRN.B
S 1998/PRY.B
S PLANT PRODUCT/TIENS FRUIT#/TIFRS FRUCHTFLEISCH/TIDES METALOPORFIRINAS/TIOLS FRUTOS/TIES
S 20210101-20210601/UPAGS MAR 2006/UPAAS 16 APR 2005/UPATS 20050509/UPCLS 208139000/INCLS 208/INCLS 208139000/INCLM/INCLSS 624/INCLS

INCL

INCL

(1) Numeric search field that may be searched using numeric operators or ranges.
(2) The words AND, IS, OF, THE, and TO are not indexed in this field.
You may use these stop words in your search statement, however at their position a (1W)-proximity is used by the system.
(3) Search with implied (S) proximity is available in this field. Bound phrases have to be searched with quotation marks.

February 2024

12
WPIDS / WPINDEX / WPIXCITATION DATA FIELDS FROM DWPI
Citation Fields – Cited Patent
Fields that allow left truncation are indicated by an asterisk (*).

Search Field Name
Citation Category
Citation Category, Cited
Cited Accession Number
Cited Inventor
Cited Patent Assignee (1)Cited Patent Assignee Code (2)Cited Patent Country
Cited Patent Date (3)Cited Patent Kind Code
Cited Patent Number
Cited Patent Year (3)Origin of Citation
Update Date, Cited (3)SearchCode/CAT/CAT.D/AN.D(or /OS.D)
/IN.D
/PA.D
/PACO.D/PC.D(or /RPC)/PD.D(or /RPD)/PK.D(or /RPK)/PN.D(or /RPN)/PY.D(or /RPY)/ORC(or /SRT)/UPD

Search Examples

Display
Codes

S BASF/PA.D(P)(X OR I)/CAT
S BASF/PA.D(P)(X OR I)/CAT.DS 2019-100035/AN.D

CDP
CDP
CDP

S BELLER M/IN.D
S HYUNDAI/PA.DS HYMR/PACO.D
S EP/PC.D

CDP
CDP
CDP
CDP

S 20200102/PD.D

CDP

S USA1/PK.D

CDP

S US20190062224/PN.D

CDP

S 2019/PY.D

CDP

S OPPOSITION/ORC

CDP

S 20211001/UPD

UPD

Citation Fields – Cited Literature
Search Field Name
Citation Category
Citation Category, Cited
Cited Non-Patent Literature*
Digital Object Identifier

Origin of Citation
Update Date, Cited (3)XP Document Number

SearchCode/CAT/CAT.D/CDL(or /REN)/DOI(or /FTDOI)/ORC(or /SRT)/UPD/XP(or /REXP)

Search Examples
S BELLER/CDL(P)(X OR I)/CATS BELLER/CDL(P)(X OR I)/CAT.D
S (TRANSDERMAL(2A)?PATCH?)/CDL

CDL
CDL
CDL

S
HTTPS://DOI.ORG/10.1109/SYSCON.2015.71
16836/DOIS ?LIPASE?/CDL(P)E/ORC

DOI, CDL

S 20211001/UPD
S XP000000013/XP

UPD
XP, CDL(1) Search with implied (S) proximity is available in this field. Bound phrases have to be searched with quotation marks.
(2) A thesaurus is available in this field.
(3) Numeric search field that may be searched using numeric operators or ranges.

February 2024

Display
Codes

CDL

13
WPIDS / WPINDEX / WPIX

Citation Fields – Citing Patents
SearchCode

Search Field Name
Citation Category
Citation Category, Citing
Citing Accesssion Number
Citing Inventor
Citing Patent Assignee (1)Citing Patent Assignee Code (2)Citing Patent Country
Citing Patent Date (3)Citing Patent Kind Code
Citing Patent Number
Citing Patent Year (3)Origin of Citation
Update Date, Citing (3)/CAT/CAT.G/AN.G(or /OS.G)
/IN.G
/PA.G
/PACO.G
/PC.G
/PD.G
/PK.G
/PN.G
/PY.G
/ORC
(or /SRT)/UPG

Display
Codes

Search Examples
S SIEMENS/PA.G(P)X/CATS SIEMENS/PA.G(P)X/CAT.G
S 2019-000006/AN.G

CGP
CGP
CGP

S SMITH A/IN.G
S ROHM HAAS/PA.G
S MICT-C/PACO.G
S AU/PC.G
S 20210105/PD.GS CNA/PK.G
S JP06000043B/PN.G
S 2017-2019/PY.G
S EP/PC.G(P)THIRDPARTY/ORC

CGP
CGP
CGP
CGP
CGP
CGP
CGP
CGP
CGP

S 20211001/UPG

UPG

Citation Count Fields
Search Code
/ANC.D (3)/ANC.G (3)/CRC (3)/PCC.D (3)/PCC.G (3)/PNC.D (3)/PNC.G (3)/REC (3)Definition
Cited DWPI Accession Number Count
Citing DWPI Accession Number Count
Cited Literature Reference Count
Cited Patents Country Count
Citing Patents Country Count
Cited Patents Count
Citing Patents Count
Cited Reference Count (total)

Display
Codes

Search Examples
S ANC.D>20
S 10-20/ANC.G
S CRC<10
S 3-5/PCC.D
S 10/PCC.G
S PNC.D>30
S 20-30/PNC.G
S REC>100

CITC
CITC
CITC
CITC
CITC
CITC
CITC
CITC

Citation Fields – Derwent Family Members with Citations
Search Code
/PC.F
/PK.F
/PN.F

Definition
Patent Country of Family Member (cited, citing)
Patent Kind Code of Family Member (cited, citing)
Patent Number of Family Member (cited, citing)

Display
Codes

Search Examples
S CN/PC.F(P)JP/PC.D
S EPB#/PK.F(P)O/ORC
S EP1003890/PN.F

CDP,CGP,CDL
CDP,CGP,CDL
CDP,CGP,CDL

Examiner Fields of Search
Search Code
/EXF.CPC/EXF.IPC/EXF.JPC/EXF.USPC

Definition
Examiner’s Field of Search, CPC
Examiner’s Field of Search, IPC
Examiner’s Field of Search, JPC
Examiner’s Field of Search, USPC

Display
Codes

Search Examples
S A61K/EXF.CPC
S C12N0005/EXF.IPC
S C07D0239-00/EXF.JPC
S 101221000/EXF.USPC

EXF, EXFA
EXF, EXFA
EXF, EXFA
EXF, EXFA(1) Search with implied (S) proximity is available in this field. Bound phrases have to be searched with quotation marks.
(2) A thesaurus is available in this field.
(3) Numeric search field that may be searched using numeric operators or ranges.

February 2024

14
WPIDS / WPINDEX / WPIX

Property Fields(1)In DWPI a numeric search for a specific set of physical properties (/PHP) is available within the English text
fields (titles, abstracts, claims). The numeric values are not displayed as single fields, but highlighted within
the hit displays.
Use EXPAND/PHP to search for all available physical properties. A search with the respective field codes will
be carried out in all database fields with English text. The /PHP index contains a complete list of codes andrelated text for all physical properties available for numeric search.
Field
Code

Property

Unit

SymbolAmount of Substance
Bit Rate
Stored Information
CapacitanceCatalytic Activity
Current Density
Molarity, Molar
Concentration
Conductance
DecibelDegreeDensity (MassConcentration
Dose Equivalent
DosageDosageMol
Bit/Second
Bit
Farad
Katal
Ampere/Square Meter
Mol/Liter

mol
bit/s
Bit
F
kat
A/m2
mol/L

S 10 /AOS
S 8000-10000/BIR
S BIT > 3 MEGABIT
S 1-10 MF/CAP
S 1-10/KATAS CDN>10 A/M**2
S UREA/BI (S) 8/CMOL

Siemens
DecibelDegreeKilogram/Cubic Meter

S
dB
°
kg/m³

S 1S-3/CON
S DB>50
S CYLINDER/BI (S) 45/DEG
S 5E-3-10E-3/DEN

SievertMilligram/Kilogram/Day
Milligram/Kilogram

Sv
mg/kg/day
mg/kg

Viscosity, dynamic
Electric Charge

Pascal * Second
Coulomb

Pa * sC

S DV>5000
S 0.0001-0.001/ECH

Electrical Conductivity

Siemens/Meter

S/mS ECO>800 S/M (15A) AQUEOUS

Electric Current

AmpereA

S 1-10/ELC

Electric Field

Volt/Meter

V/m

S 200/ELF

Energy

Joule

J

/ERE
(/ERES)/FOR/FRE (/F)/IU/KVElectrical Resistivity

Ohm * MeterS DROPLETS (10A) 40 JOULE 70 JOULE /ENES ERE>0.1

Force
Frequency
International Unit
Viscosity, kinematic

NewtonHertz
none
Square Meter/Second

N
Hz
IU
m2/s

/LEN
(/SIZ)/LUME

Length, Size

Meter

m

S 50 N /FORS OSCILLAT?/BI (S) 1- 3/FRE
S IU>1000 (P) VITAMIN AS METHYLPOLYSILOXANES/BI (10A)
200-300 CST/KV
S 1-4/LEN

Luminous Emittance,
IlluminanceLuminous Flux
Luminous Intensity
Mass
Mass to Charge Ratio

Lux

lx

S 10-50/LUME

Lumen
CandelaKilogram
none

Lm
cd
kg
m/z

S LUMF>1000
S LUMI<4
S ALLOY/BI (30A) 1E-10-1E-5/M
S MCH=1

/AOS
/BIR
/BIT
/CAP
/CATA
/CDN
/CMOL
/CON
/DB
/DEG
/DEN (/C)
/DEQ
/DOA
/DOS
(/LD50)/DV/ECH(/CHA)/ECO(/ECND)/ELC(/ECC)/ELF(/ECF)
/ENE

/LUMF
/LUMI
/M
/MCH

February 2024

Ohm * mSearch Examples

S 100/DEQ
S 300/DOAS DOS>0.8

15
WPIDS / WPINDEX / WPIX

Property Fields(1) (cont’d)
Field
Code

Property/MFD(/MFS)/MFR(/MFL)/MFST

Magnetic Flux
Density
Mass Flow Rate

Tesla

T

S MFD>102

Kilogram/Second

kg/s

S MFR<0.1

Magnetic Field
Strength
Molar Mass

Ampere/Meter

A/m

S 40-50/MFST

Gram/Molg/mol

S 2000-3000 G/MOL/MM

Molality of Substance
Melt Volume Rate,
Melt Flow Rate
Percent(Proportionality)
pH Value

Mol/Kilogramnone

mol/kgg/10 minS 01.-10 MOL/KG/MOLS
S 3/MVR/MM (/MW,
/MOM)
/MOLS
/MVR
/PER

Unit

Symbol

Search Examples

none

%

S POLYMER?/AB (5A) 4/PER

pH

pH

S 7.4-7.6/PHV

Power

Watt

W

Parts per million

PPM

ppm

/PRES (/P)

Pressure

Pascal

Pa

/RAD
/RES
/RI
/RSP

Radioactivity
Electrical ResistanceRefractive Index
Rotational Speed

Becquerel
Ohmnone
Revolution/Minute

Bq
Ohm

/SAR

Area /Surface Area

Square Meter

m²

/SOL
(/SLB)/SSAM

Solubility

Gram/100 gram

g/100 gS "HG-XE-?"/BI (S) 100-200
WATT/POW
S 100 PPM /PPM (10A)
ADDITIVE/BI
S (VACUUM (5A) DISTILL?)/BI (S)1000-1100/PRES
S 1-10/RAD
S SENSOR /BI (S) 10- 100/RES
S 3-4/RIS 2 RPM - 100 RPM /RSP (S)ENGINE/BIS PLATE/BI (S) 10 M**2 - 100
M**2 /SARS SOL>20 G/100G (5A) WATER

Specific Surface
Area, Mass
Surface Tension,
Spring Constant
Thermal Conductivity

Square Meter/
Kilogram
Joule /Square Meter

m2/kg

S 9/SSAM

J/m²

S 60 J/M**2/STSC

Watt/Meter * Kelvin

W/m * K

S 1/TCO (S) HEAT?

Temperature
Tex
Time

KelvinGram/Kilometer
SecondK
g/kms/VEL (/V)
/VELA
/VLR

Velocity
Velocity, Angular
Volumetric Flow Rate

Meter per Second
Radian/Second
Cubic Meter/Second

m/s
rad/s
m³/s

/VOL
/VOLT

VolumeVoltage

Cubic Meter
Volt

m³
V

/PHV
(/PH)
/POW
(/PW)
/PPM

/STSC
/TCO
(/TCND)/TEMP (/T)
/TEX
/TIM

rpm

S 20-25/TEMP
S 1-5/TEXS ?INCUB?/BI (10A) 50 S - 150 S/TIM
S REDUC?/BI (S) 1E-3-5E-3/VELS VELA>10
S 1 M**3/S - 2 M**3/S /VLR (S)ABRASIVE
S 1E-8-2E-8/VOL.EXS TENSION/BI (10A) 5E-3 V<VOLT<7E-3 V(1) Exponential format is recommended for the search of particularly high or low values, e.g. 1.8E+7 or 1.8E7 (for 18000000) or 9.2E-8(for 0.000000092).

February 2024

16
WPIDS / WPINDEX / WPIXIPC Thesaurus
The classifications and catchwords for the main headings and subheadings from the current (8th) edition of
the WIPO International Patent Classification (IPC) manual are available. The classifications from the previous
editions (1-7) are also available as separate thesauri. To EXPAND and SEARCH in the thesauri for editions
1-7, use the field code followed by the edition number, e.g., /IPC2, for the 2nd edition. Catchwords areincluded only in the thesauri for the 8th, 7th, 6th, and 5th editions.
Relationship
Code
ADVANCED (ADV)ALL
BRO (MAN)BT
CORE (COR)
ED
HIE
INDEX
KT
NEXT
NT
PREV
RT (SIB)
TI

Content

Search Examples

Advanced Codes for the Core Level IPC code
All Associated Terms (BT, SELF, NT, RT)
Complete Class
Broader Term (SELF, BT)
Core Codes for the Advanced Level IPC code
Complete title of the SELF term and IPC manual
edition
Hierarchy Term (Broader and Narrower Term)(BT, SELF, NT)
Complete title of the SELF term
Keyword Term (catchwords) (SELF, KT)

E A61K006-02+ADV/IPC
E C01C003-00+ALL/IPC
E C01C+BRO/IPC
E C01F001-00+BT/IPC
E C03B0001-02+COR/IPC
E C01F001-00+ED/IPC

Next Classification
Narrower Terms (SELF, NT)
Previous Classification
Related Terms (SELF, RT)
Complete Title of the SELF Term and Broader
Terms (BT, SELF)

E C01C001-00+NEXT5/IPC
E C01C+NT/IPC
E C01C001-12+PREV10/IPC
E C01C003-20+RT/IPC
E C01F001-00+TI/IPC

E C011003-00+HIE/IPC
E C01F001-00+INDEX/IPC
E CYANOGEN+KT/IPC

CPC, ECLA (/EPC) and ICO Thesauri
These thesauri are available in the /CPC search field, /EPC search field (for ECLA codes) and /ICO search
field (‘in-computer-only’) Classification. All relationship codes can be used with both the EXPAND and
SEARCH commands.
Relationship
Code

Content

ALL
AUTO (1)BT
CODE

All usually required terms (BT, SELF, CODE, DEF)
Automatic relationship (BT, SELF, CODE, DEF)
Broader terms (BT, SELF)
Classification Code (SELF, CODE)

DEF
HIE

Definition (SELF, DEF)
Hierarchy terms (all broader and narrower terms) (BT,SELF, DEF, NT)
Keyword terms (SELF, KT)
All associated terms
Next classification within the same class (SELF, NEXT)
Next n classification within the same class
Narrower termPrevious Code within the same class (SELF, PREV)
Previous n classifications within the same class
Complete Title of the SELF Term and Broader
Terms (BT, SELF)

KT
MAX
NEXT
NEXT(n)NT
PREV
PREV(n)TI

Search Examples
E C12M0001-34H2+ALL/EPC
E G01J003-443+AUTO/EPC
E G01J0003-443+BT/EPC
E SCRAPER BIASING
MEANS+CODE/EPC
E B65G0045-16+DEF/EPC
E A01B0001+HIE/EPC
E LASER+KT/EPC
E G01J0003-44B+MAX/EPC
E A01B0001-24+NEXT/EPC
E A01B0001-24+NEXT3/EPC
S G05B0001-03+NT/EPC
E L60H0001:00A+PREV/ICO
E L60H0001:00A+PREV1/ICO
E G05B0001-03+TI/EPC(1) Automatic Relationship is SET OFF. In case of SET REL ON the result of EXPAND or SEARCH without any relationship code is thesame as described for AUTO.

February 2024

17
WPIDS / WPINDEX / WPIX

F-Term (/FTERM) Thesaurus
This thesaurus is available in the F-Term (/FTERM) field that contains patent classification from the Japanese
Patent Office from February 2009 to the present.
Relationship
Code
ALL
BT
CODE
DEF
HIE
KT
NT
RFI
TI

Content

Search Examples

All associated terms (BT, SELF, NT, RT)
Broader Term (SELF, BT)
Code for the thesaurus text term
Definition
Hierarchy Terms (all broader and narrower terms)
Keyword Term
Narrower Term
Related FI (File Indexing) classification Term
Complete Title of the SELF Term and Broader
Terms (BT, SELF)

E 2B002/AA05+ALL/FTERM
E 2B002/AA05+BT/FTERM
E 2B002/BA13+CODE/FTERM
E 2B002/BA13+DEF/FTERM
E 2B002/AA05+HIE/FTERM
E 2B002/AA05+KT/FTERM
E 2B002/AA09+NT/FTERM
E 2B002/AA09+RFI/FTERM
E 2B002/AA09+TI/FTERM

FI-Term (/FCL) Thesaurus
This thesaurus is available in the FI-Term (/FCL) field that contains patent classification from the Japanese
Patent Office.
Relationship
Code
ALL
BT
DEF
HIE
INDX
MAX
NOTE
NT
RT
TI

Content
All usually required associated terms
Broader Term (SELF, BT)
Definition
Hierarchy Terms (all broader and narrower terms)
Index Note
All associated Terms
Scope Notes
Narrower Term
Related Term
Complete Title of the SELF Term and Broader
Terms (BT, SELF)

Search Examples
E A01B0003-00+ALL/FCL
E H02B0001-02+BT/FCL
E H05B0041-392+DEF/FCLS H02B0001-02C+HIE/FCL
E C07C CSP+INDX/FCL
E B01B0001-08+MAX/FCLE B23D+NOTE/FCL
E H05B0041-392+NT/FCL
E H05B+RT/FCL
E A01B0001-12+TI/FCLUS National Patent Classification (/NCL) Thesaurus
The US National Patent Classification thesaurus is available online in field /NCL. All relationship codes can beused with both the EXPAND and SEARCH commands.
Relationship
Code
ALL
AUTO (1)
BT
CODE
DEF
HIE
KT
MAX
NEXT
NEXT(n)NT
PREV
PREV(n)TI

Content
All usually required terms (BT, SELF, DEF, NT)
Automatic relationship (BT, SELF, DEF, NT)
Broader Terms (BT, SELF)
Classification Code (SELF, CODE)
Definition (SELF, DEF, DEF2, DEF3, DEF4)
Hierarchy Terms (BT, SELF, DEF, NT)
Keyword Terms (SELF, KT)
All associated Terms (BT, SELF, DEF, DEF2, DEF3,
DEF4, NT, KT)
Next classification within the same class
Next n classifications within the same class
Narrower Terms (SELF, NT)
Previous Code within the same class
Previous n classifications within the same class
Complete title of the SELF and the Broader Terms
including their definitions (BT (DEF), SELF, DEF)

Search Examples
E 257E21685+ALL/NCL
E 02416300R+AUTO/NCL
E 02416300R+BT/NCL
E APPAREL+CODE/NCL
E G9B031001+DEF/NCL
E 23548700+HIE/NCL
E APPAREL+KT/NCL
E G9B031000+MAX/NCL
E G9B033035+NEXT/NCL
E G9B033035+NEXT2/NCL
S 257E21685+NT/NCL
E 235462260+PREV/NCL
E 235462260+PREV3/NCL
E 052002110+TI/NCL(1) Automatic Relationship is SET OFF. In case of SET REL ON the result of EXPAND or SEARCH without any relationship code is thesame as described for AUTO.
February 2024

18
WPIDS / WPINDEX / WPIX

Manual Codes Thesauri (CPI AND EPI)
Field

Relationship
Code

/MC

ALL
AUTO (1)BT
NT

Content
All Associated Terms (BT, SELF, HNTE, DEF,
NT)
Automatic Relationship (SELF, HNTE, DEF)
Broader Terms (BT, SELF)
Narrower Terms (NT, SELF)

Search Examples
E A03-A04A1+ALL/MC
E S01-B05+AUTO/MCE S06-B02A+BT/MCS S06-B02+NT/MC(1) Automatic Relationship is SET OFF. In case of SET REL ON the result of EXPAND or SEARCH without any relationship code is thesame as described for AUTO.

DWPI Title Terms
The automatic relationship is SET ON by default, so that forbidden terms will cause automatic retrieval of thepreferred terms in a SEARCH.

Field
/TT

Relationship
Code
ALL
AUTO (1)UF
USEContent
All Associated Terms (SELF, USE, UF)
Automatic Relationship (SELF, USE)
Used for (Preferred and Forbidden Terms SELF, UF)
Use (Forbidden and Preferred Terms – SELF,
USE)

Search Examples
E ABLATION+ALL/TT
S ABLATE+AUTO/TT
E FABRICATE+UF/TTS FABRICATED+USE/TT(1) Automatic Relationship is SET OFF. In case of SET REL ON the result of EXPAND or SEARCH without any relationship code is thesame as described for AUTO.

Patent Assignee Code Dictionary
The list of Clarivate (UK) Limited-assigned company codes for patent assignees matched with company
names is available in field /PACO. This feature allows you to easily and comprehensively identify thecompany names associated with a code, or to identify the code(s) used for a company name. Expanding infield /PACO (Patent Assignee Code) provides the alphabetical list of codes, single words and the full namefrom the company field (/PA). Each code is listed with its frequency in field /PACO and with the number ofassociated terms (AT) in the dictionary.

Field
/PACO

February 2024

Relationship
Code
ALL
DEF

Content
All patent assignee code(s) defined for the nameAll name definitions for the given code

Search Examples
E BAYER+ALL/PACOE FARB+DEF/PACO

19
WPIDS / WPINDEX / WPIX

Polymer Indexing Thesaurus
DWPI Polymer Indexing Thesaurus is available online in field /PLE. All relationship codes can be used withboth the EXPAND and SEARCH commands.

Field

Relationship
Code

/PLE

ALL
AUTO (1)Content

Search Examples

All Associated Terms (BT, SELF, NOTE, USE,
SEE, UF, NT, RT)
Automatic Relationship (SELF, USE, UF)

E Q8457+ALL/PLE
E CANS<APPLICATIONS>+ALL/PLE
E BY-PRODUCTS/PLE
S E4+AUTO
E Q8457+BT/PLE

RTUF

Broader Terms (also BT1=1st Level, BT2=2nd
Level, etc.)
Hierarchy Terms (BT, SELF, NT)
Keyword Terms (Multi-word Phrases
containing the specified Keyword Term)
Narrower Terms (also NT1=1st Level, NT2=2nd
Level, etc.)
Related Terms (see also)
Used for (Preferred and Forbidden Terms)

USE

Use (Forbidden and Preferred Terms)

BT
HIE
KT
NT

E Q8399+HIE/PLE
E POLYOL+KT/PLE
E Q8399+NT/PLE
E Q7034+RT/PLE
E DIELECTRIC CONSTANT<PROPERTIES>+UF/PLE
E POWER FACTOR/PLE(1) Automatic Relationship is SET OFF. In case of SET REL ON the result of EXPAND or SEARCH without any relationship code is thesame as described for AUTO.

Plasdoc Key Serials Dictionary
The Plasdoc Key Serials codes in field /KS can be looked up in an online dictionary. You may expand on thedefinitions for the codes in field /KS, e.g., => E GASEOUS/KS will provide an alphabetical list around the termgaseous. The list also shows the number of codes associated with the term (AT column).

Field

Relationship
Code

/KS

ALL

Content
All Associated Terms (CODE, DEF)

Search Examples
E GASEOUS+ALL/KS

DWPI Compound Numbers (/DCN) Thesaurus
For DWPI Compound Numbers (/DCN), the USE/UF relationships are available to see the definitions. All
relationship codes can be used with both the EXPAND and SEARCH commands.

Field
/DCN

Relationship
Code
ALL
UF
USE

Content
All associated terms (SELF, USE, UF)
Used for terms (SELF, UF)
Use terms (SELF, USE)

Search Examples
E R09609+ALL/DCN
E R22401+UF/DCN
E ACETIC ACID+USE/DCN

DWPI Registry Numbers (/DRN) Thesaurus
For DWPI Registry Numbers (/DRN), the USE/UF relationships are available to see the definitions. All
relationship codes can be used with both the EXPAND and SEARCH commands.

Field
/DRN

Relationship
Code
ALL
UF
USE

Content
All associated terms (SELF, USE, UF)
Used for terms (SELF, UF)
Use terms (SELF, USE)

Search Examples
E 0495+ALL/DRN
E 1314+UF/DRN
E ACETIC ACID+USE/DRN

February 2024

20
WPIDS / WPINDEX / WPIXDWPI Invention LevelDISPLAY and PRINT Formats
Any combination of formats may be used to display or print answers. Multiple codes must be separated by
spaces or commas, e.g., D L1 1-5 TI AU. The fields are displayed or printed in the order requested.
Hit-term highlighting is available for all fields. Highlighting must be ON during SEARCH to use the HIT, KWIC,
and OCC formats.
FormatAB
ABDT (1)ABEQ
ABEX (1)ACTN
ACTV
ADT (2)
ADT.B (2)ADV
AI (AP) (2)
AI.B
ALE
AN
ANX
AW
CMC
CPC
CPC.TABCR (XR)
CYC
DC
DCN
DCR
DCRU
DETD
DN
DNC
DNN
DRN
DRWD
DRWN
DS
DUPD
ED
EPC (ECLA, EPCLA)FA
FCL (JPC)
FDT
FG (AM)FS
FTRM (FTERM, FTCLA,
JPCLA)
GI
GINF (GIS)
IC
ICA
ICI
ICM
ICO

February 2024

Content

ExamplesAbstract (contains value-added data)
Abstract, Documentation
Abstract, Equivalent
Abstract, Extension
Mechanism of Action
Activity
Application Details
Application Details, Basic
Advantage
Application Information
Application Information, Basic
Alerting Abstract, First Section
Accession Number
Crossover Accession Number
Additional Words
Chemical CodeCooperative Patent Classification
CPC, Tabular Display of CPC, CPC.KW, CPC.ACD, CPC.VER
Cross Reference
Country CountDWPI ClassDWPI Compound Number
Chemical Resource Number
Chemical Resource Number, Unlinked
Detailed Description
Document Number (DNC and DNN)
Document Number CPI
Document Number Non-CPI
DWPI Registry Number
Description of Drawings
Number of Drawings
Designated StateDWPI Update (formerly Derwent Week), first and latest
Entry Date
European Patent Classification
Field Availability
Japanese Patent Office Classification (FI-Terms)
Filing Details
Fragmentation Code (PLASDOC)
File Segment
Japanese Patent Office Classification (F-Terms)

D AB
D ABDT
D ABEQD ABEXD ACTND ACTV
D ADT
D ADT.B
D ADV
D AI
D AI.B
D ALE
D AN
D ANX
D AW
D CMC
D CPC
D CPC.TAB
D CR
D CYC
D DC
D DCN
D DCR
D DCRUD DETD
D DN
D DNC
D DNN
D DRN
D DRWD
D DRWND DS
D DUPD
D ED
D EPC
D FA
D FCL
D FDT
D FG
D FS
D FTRM

Graphic Information
Graphic Image(s) Information
IPC, Main and Secondary (IPC 1-7)
IPC, Additional (supplementary, IPC 1-7)
IPC, Index (complementary, IPC 1-7)
IPC, Main (IPC 1-7)
ICO (in-computer-only) Classification

D GI
D GINF
D IC
D ICA
D ICI
D ICM
D ICO

21
WPIDS / WPINDEX / WPIXDWPI Invention LevelDISPLAY and PRINT Formats (cont’d)FormatICSIN (AU)
IPC
IPC.TABIPCIIPCR
IT (KW)
KS
M0-M6
MC
NCL
NOV
PA (CS)PATS
PI (2,3)
PI.B (2,3)
PLC
PLE
PN (2,3)
PN.B
PNK
PNK.B
PNC
PRAI (PRN) (2)
RIN
RINU
TECH
TI
TT
UADV
UP
UPA
UPAB
UPB
UPCP
UPFT
UPIC
UPIN
UPIT (UPKW)
UPPA
UPMC
UPP
UPS
UPTI
USE

Content
IPC, Secondary (IPC 1-7)
Inventor
International Patent Clasification (ICM, ICS, ICA, ICI, IPCI, IPCR)
IPC, Tabular Display of IPC, IPC.KW, IPC.ACD, IPC.VER
IPC, Initial
IPC, Reclassified
Index Term
Plasdoc Key Serials
Chemical Codes
Manual CodeUS National Patent Classification, Current
Novelty
Patent Assignee
Patent Number Group
Patent Information (including designated states)
Patent Information, Basic
Polymer Coding Plasdoc
Polymer Indexing Enhanced
Patent Information (without designated states)
Patent Information, Basic (without designated states)
Patent Number/Kind CodePatent Number/Kind Code, Basic
Patent Number Count
Priority Information
Ring Index Number
Ring Index Number, unlinked
Technology Focus
Title
Title Terms
Use/Advantage Section
Update Date
Update Date Polymer Indexing
Update Date Abstract
Update Date Chemical CodeUpdate Date Cooperative Patent Classification
Update Date Japanese Patent Classification
Update Date International Patent Classification
Update Date Inventor
Update Date Index Term
Update Date Patent Assignee
Update Date Manual CodeUpdate Date Patent Family
Update Date SDI
Update Date Enhanced Title
Use

Examples
D ICS
D IN
D IPC
D IPC.TAB
D IPCID IPCR
D IT
D KS
D M0
D MC
D NCL
D NOV
D PA
D PATS
D PI
D PI.B
D PLC
D PLE
D PN
D PN.BD PNK
D PNK.B
D PNC
D PRAI
D RIN
D RINUD TECH
D TI
D TT
D UADV
D UP
D UPA
D UPAB
D UPB
D UPCPD UPFTD UPICD UPIND UPITD UPPAD UPMCD UPP
D UPS
D UPTI
D USE(1) This field is available in WPIX only.
(2) Application, priority and patent numbers are available in Derwent and STN format. The format for DISPLAY, PRINT, SELECT and
SORT is controlled by the Messenger SET PATENT command. The STN format is default. 'SET PAT DERWENT' changes(permanently) to the Derwent format. To change to the STN format again, enter 'SET PAT STN'.
(3) Basic patents are identified with an asterisk (*), Equivalent-Treated-as-Basic are identified with a capital letter B, and NonConventional Equivalents are identified with a hash mark (#).

February 2024

22
WPIDS / WPINDEX / WPIXDWPI Invention Level
Predefined Formats
FormatABS
ALL (1)

ALLG (1)DALL (1)
IALL (1)
IALL.G (1)ANL
APPS (1)BASIC (1)BIB (1)IBIB (1)BRIEF
BRIEFGIBRIEFIBRIEFG
CODE (IND)
CPC.TABFAM (1)
FULL (1,2)

FULLG (1,2)
IFULL (1,2)
IFULLG (1,2)
IPC
IPC.TABMAX (1,2)

MAXG (1,2)
IMAX (1,2)
IMAXG (1,2)
PATS (1)
SCAN (3)STD (1)ISTD (1)
SUM
TRIAL (TRI, SAMPLE,
SAM)
UPP

Content

ExamplesAN, CR, AB, UPAB, ABEQ
All invention level data available for a given record, excluding theEquivalent (ABEQ), Documentation (ABDT), and Extension (ABEX)
abstracts and the chemical coding and polymer indexing: AN, CR, ANX,
DNC, DNN, TI, DC, IN, PA, CYC, PN, ADT, FDT, PRAI, IPC, CPC, EPC,
ICO, NCL, FCL, FTRM, AB, UPAB, FS, MC. Short compressed version.
ALL, plus graphic image
ALL, delimited for post processing
ALL, indented with text labels
ALLG, indented with text labels
Accession Number List only
ADT, PRAI
AN, CR, ANX, DNC, DNN, TI, DC, IN, PA, PNC, CYC, PN.B, ADT.B,
PRAI, AB, UPAB, FS
AN, CR, DNC, DNN, TI, DC, IN, PA, CYC, PI, ADT, FDT, PRAI
BIB, indented with text labels
AN, CR, ANX, DNC, DNN, TI, DC, PA, AB, UPAB
BRIEF, plus graphic image
BRIEF, indented with text labels
BRIEFG, indented with text labels
AN, DC, IPC, CPC, EPC, ICO, NCL, FCL, FTRM, MC, IT, DRN, PLC,
PLE, CMC
Cooperative Patent Classification, Tabular Display
PI, ADT, FDT, PRAI
All invention level data available for a given record plus Technology
Focus (TECH) and Documentation (ABDT) or Extension abstracts(ABEX), excluding the Equivalent abstracts (ABEQ) and the chemicalcoding and polymer indexing: AN, CR, ANX, DNC, DNN, TI, DC, IN, PA,
CYC, PN, ADT, FDT, PRAI, IPC, CPC, EPC, ICO, NCL, FCL, FTRM, AB,
UPAB, TECH, ABEX, ABDT, FS, MC. Short compressed version.
FULL, plus graphic image
FULL, indented with text labels
FULLG, indented with text labels
IC (ICM, ICS), ICA, ICI, IPCI, IPCR
International Patent Classification, Tabular Display
All invention level data available for a given record, including the chemicalcoding, and polymer indexing as well as Equivalent (ABEQ),
Documentation (ABDT) and Extension (ABEX) abstracts: AN, ED, CR,
ANX, DNC, DNN, TI, AW, DC, IN, PA, CYC, PN, ADT, FDT, PRAI, IPC,
CPC, EPC, ICO, NCL, FCL, FTRM, AB, UPAB, SL, ABEQ, TECH, ABEX,
ABDT, IT, FS, MC, PLC, PLE, CMC
MAX, plus GI, GINF
MAX, indented with text labels
MAXG, indented with text labels
PI, FDTAN, TI (random display, no answer numbers)
AN, CR, DNC, DNN, TI, DC, IN, PA, CYC, PN, ADT, FDT, PRAI, IPC(STD is the default)
STD, indented with text labels
AN, TI, NOV
AN, CR, ANX, DNC, DNN, TI, DC, IPC, CPC, EPC, ICO, MC

D TI PA ABS
D ALL

Update Patent Family (patent family iInformation plus update dates)

D UPP

D ALLGD DALLD IALLD IALL.G
D ANL
D APPS
D BASICD BIB
D IBIB
D BRIEF
D BRIEFGD IBRIEF
D IBRIEFG
D CODE
D CPC.TAB
D FAM
D FULLD FULLGD IFULL
D IFULLG
D IPC
D IPC.TAB
D MAX

D MAXGD IMAXD IMAXGD PATSD SCAND STD
D ISTD
D SUM
D TRIAL(1) Application, priority and patent numbers are available in Derwent and STN format. The format for DISPLAY, PRINT, SELECT and
SORT is controlled by the Messenger SET PATENT command. The STN format is default. 'SET PAT DERWENT' changes(permanently) to the Derwent format. To change to the STN format again, enter 'SET PAT STN'.
(2) ABDT and ABEX are available in WPIX only.
(3) SCAN must be specified on the command line, i.e., D SCAN or DISPLAY SCAN.

February 2024

23
WPIDS / WPINDEX / WPIX

Additional DWPI Individual Patent Publication (often First Level Data)
Display and Print Formats
Format
ABDE
ABEN
ABES
ABFR
ABOL
AG
AG.T
AGA
APTS
CLM
CLMDE (1)
CLMEN (1)
CLMES (1)
CLMFR (1)
CLMOL (1)
GI.M
IIC
IICA
IICI
IICM
IICS
IN.T
INA
INCL
INO
IPC.TAB.M
PA.T
PAA
PAO
PRTS
TIDE
TIEN
TIES
TIFR
TIOL
UPAA (1)
UPAG (1)UPAT (1)UPCL

Content
Abstract, Original, in German
Abstract, Original, in English
Abstract, Original, in Spanish
Abstract, Original, in French
Abstract, Original, in other languages
Agent
Agent, Total
Agent Address
Application Information, Clarivate
Claims (all languages)
Claims in German
Claims in English
Claims in Spanish
Claims in French
Claims in other languages
Graphic Information, Member Patent
IPC, Initial (IICM, IICS)
IPC, Initial, Additional (supplementary)
IPC, Initial, Index (complementary)
IPC, Initial, Main
IPC, Initial, Secondary
Inventor, Total
Inventor Address
National Classification, Issued
Inventor, Original
International Patent Classification, Tabular Display
Patent Assignee, Total
Patent Assignee Address
Patent Assignee, OriginalPriority Application Information, Clarivate
Title, Original, in German
Title, Original, in English
Title, Original, in Spanish
Title, Original, in French
Title, Original, in other languages
Update Date Author Abstract
Update Date Agent
Update Date Author Title
Update Date Claim

ExamplesD ABDED ABEND ABES
D ABFRD ABOLD AG
D AG.T
D AGA
D APTS
D CLM
D CLMDED CLMEND CLMESD CLMFRD CLMOL
D GI.M
D IIC
D IICAD IICID IICM
D IICSD IN.T
D INA
D INCLD INO
D IPC.TAB.M
D PA.T
D PAA
D PAO
D PRTSD TIDE
D TIEND TIES
D TIFRD TIOLD UPAAD UPAGD UPAT
D UPCL(1) Custom display only.

February 2024

24
WPIDS / WPINDEX / WPIX

Additional DWPI Individual Patent Publication (often First Level Data)
Predefined Formats
FormatCPC.TAB.M
IPC.TAB.M
MEMB (1)MEMBG (1)MEMBB (1)

MEMBF (1,2)

MEMBFG (1,2)

Content

ExamplesCooperative Patent Classification, tabular display, individual members
International Patent Classification, tabular display, individual members
All additional publication level data available for a given record including
original abstracts and claims, as well as fields showing publication levelcomposition: PN, TIEN, TIDE, TIFR, TIES, TIOL, AG, IN, INO, INA, PA,
PAO, PAA, ADT, APTS, FDT, PRAI, PRTS, IPC, IIC, IICI, IICA, CPC,
EPC, ICO, NCL, INCL, FCL, FTRM, ABEQ, ABEN, ABDE, ABFR, ABES,
ABOL, CLM, UPCLMEMB, short compressed version, plus graphic image
All additional publication level data available for a given record including
original abstracts and claims, as well as fields showing publication levelcomposition: PN, TI, TIEN, TIDE, TIFR, TIES, TIOL, AG.T, IN.T, PA.T,
ABEN, ABDE, ABFR, ABES, ABOL, CLM
All publication level data available for a given record
AN, ED, CR, ANX, DNC, DNN, TI, TIEN, TIDE, TIFR, TIES, TIOL, AW,
DC, AG, IN, INO, INA, PA, PAO, PAA, CYC, PN, ADT, APTS, FDT, PRAI,
PRTS, IPC, IIC, IICI, IICA, CPC, EPC, ICO, NCL, INCL, FCL, FTRM, AB,
ABEQ, TECH, ABEX, ABDT, ABDE, ABEN, ABFR, ABES, ABOL, CLM,
UPCL, IT, FS, MC, FA
MEMBF, plus graphic image

D CPC.TAB.M
D IPC.TAB.M
D MEMBD MEMBG
D MEMBBD MEMBF

D MEMBFG(1) Application , priority and patent numbers are available in DERWENT and STN format. The format for DISPLAY, PRINT, SELECT and
SORT is controlled by the Messenger SET PATENT command. The STN format is default. 'SET PAT DERWENT' changes(permanently) to the DERWENT format. To change to the STN format again, enter 'SET PAT STN'.
(2) ABDT and ABEX are available in WPIX only.

DWPI Citation Data Predefined Display Formats
Format
CITD (RE)
CITDA
CITN
CITNA

Content
EXF, CDP, CDL
EXFA, CDPA, CDLA
CITC, EXF, CDP, CDL, CGP
CITC, EXFA, CDPA, CDLA, CGPA

ExamplesD CITDD CITDAD CITND CITNA

Special Formats with Hit Term Highlighting
FormatHIT
HITCMCHITCODEHITMEMBHITPLCHITPLE
KWIC
OCC

February 2024

Content
All fields containing hit terms
Hit chemical coding
DC, IPC, CPC, EPC, NCL, FCL, FTRM, IT, DRN, MC, PLC, PLE, CMC;
containg hit terms
All individual publications containing hit terms
Hit polymer coding
Hit polymer indexing
All hit terms plus a maximum of 50 words on either side
List of display fields containing hit terms

Examples
D HIT
D HITCMCD HITCODED HITMEMBD HITPLC
D HITPLE
D KWIC
D OCC

25
WPIDS / WPINDEX / WPIXHIT Structure Formats for DCR and DWPIM HIT Structures
FormatALLSTRHITSTR
FRAGHITSTR
AHITSTR
BHITSTR
FHITSTR

Content

ExamplesAll DCR structures pertaining to the DWPI record including AN.S, CN.P,
CN.S, MF
DCR hit structure(s) including AN.S, CN.P, CN.S, MF
DCR structure for a fragmentation code hit paragraph
Assembled DWPIM HITSTR including parts of the Markush structure
Assembled DWPIM HITSTR plus definitions for unmatched G-groups
that are visible in the assembled display
Complete DWPIM HIT Markush structure(s)D ALLSTRD HITSTRD FRAGHITSTR
D AHITSTRD BHITSTRD FHITSTRDWPI Invention Level
SELECT, ANALYZE, and SORT Fields
The SELECT command is used to create E-numbers containing terms taken from the specified field in ananswer set.
The ANALYZE command is used to create an L-number containing terms taken from the specified field in ananswer set.
The SORT command is used to rearrange the search results in either alphabetic or numeric order of thespecified field(s).

Field Name
Accession Number
Activity
Application Country
Application Country, Basic
Application Date
Application Date, Basic
Application Number
Application Number Group
Application Number, Basic
Application Number, Year
Application Year
Application Year, Basic
Chemical Resource Number
Chemical Resource Number, unlinked
Chemical Resource Number, with role
Cooperative Patent Classification
Country Count
Cross Reference
Crossover Accession Number
Designated State
Document Number (DNC and DNN)
Document Number CPI
Document Number Non CPI
DWPI ClassDWPI Compound Number
DWPI Registry Number
DWPI Update (formerly Derwent Week)
DWPI Update (formerly Derwent Week), first and latest
DWPI Update, Basic (formerly Derwent Week)
Entry Date
European Patent Classification
File Segment

Field Code
AN
ACTV
AC
AC.B
AD
AD.B
AP (AI, ADT)
APPS
AP.B (AI.B)
AP.YR
AY
AY.B
DCR
DCRU
DCR.WRCPC
CYC
CR (XR)
ANX
DS
DN
DNC
DNN
DC
DCN
DRN
DW
DUPD
DW.B
ED
EPC (ECLA,EPCLA)FSANALYZE/
SELECT (1)

SORT

Y
Y
Y
Y (5)
Y (5)
Y (5)
Y (2,5)
Y (2,3)
Y (2,5)
Y
Y (5)
Y (5)
Y (5)
Y (5)
Y (5)
Y
Y
Y
Y
Y (5)
Y (4)
Y
Y
Y
Y (5)
Y (5)
Y
Y
Y
Y
Y

Y
N
N
N
N
N
Y
N
N
N
N
N
N
N
N
N
Y
N
N
N
N
Y
Y
Y
N
N
N
Y
N
Y
N

Y

Y

February 2024

26
WPIDS / WPINDEX / WPIXDWPI Invention Level
SELECT, ANALYZE, and SORT Fields (cont’d)Field Name

Field CodeFiling Details
Filing Details, Patent Country
Filing Details, Patent Kind
Filing Details, Patent Number
Filing Details, TypeICO (in-computer-only) Classification
Index term
International Patent Classification (ICM, ICS, ICA, ICI, IPCI, IPCR)
Inventor
IPC, Additional (supplementary, IPC 1-7)
IPC, Index (complementary, IPC 1-7)
IPC, Main (IPC 1-7)
IPC, Main and Secondary (IPC 1-7)
IPC, Main or First
IPC, Secondary (IPC 1-7)
Japanese Patent Classification (FI-Terms)
Japanese Patent Classification (FI-Terms, additional)
Japanese Patent Classification (FI-Terms, index)
Japanese Patent Classification (FI-Terms, main)
Japanese Patent Classification (FI-Terms, secondary)
Japanese Patent Classification (F-Terms)

FDT
FDT.PC (RLPC)
FDT.PK (RLPK)
FDT.PN (RLPN)
FDT.TPICO
IT (KW)
IPC
IN (AU)
ICA
ICI
ICM
IC
IPC.F
ICS
FCL (JPC)
FACL
FICL
FMCL
FSCL
FTRM (FTERM,FTCLA, JPCLA)
LA
MC
MCN
MCN.WR
PA
PACO
PAX
PCS
PC
PC.B
PD
PD.B
PN (PI)
PN.B
PK
PK.B
PNC
PATS
PNK
PNK.B
PRC
PRCF
PRC.B
PRD
PRDF
PRD.B
PRN (PRAI)
PRNF
PRN.B
PRN.YR

Language
Manual Code
Markush Compound Number
Markush Compound Number, with Role
Patent Assignee
Patent Assignee CodePatent Assignee Code and Name
Patent Countries
Patent Country
Patent Country, Basic
Patent Date
Patent Date, Basic
Patent Information
Patent Information, Basic
Patent Kind CodePatent Kind Code, Basic
Patent Number Count
Patent Number Group (PN, FDT.PN)
Patent Number/Kind CodePatent Number/Kind Code, BasicPriority Country
Priority Country First
Priority Country, BasicPriority Date
Priority Date First
Priority Date, BasicPriority Number
Priority Number First
Priority Number, BasicPriority Number, Year

February 2024

ANALYZE/
SELECT (1)

SORT

Y (5)
Y (5)
Y (5)
Y (5)
Y
Y
Y (5)
Y
Y
Y
Y
Y
Y
Y (6)
Y
Y (5)
Y (5)
Y (5)
Y (5)
Y (5)
Y

N
N
N
N
N
N
N
N
Y
N
N
Y
N
Y
N
N
N
N
Y
N
N

Y
Y
Y (5)
Y (5)
Y
Y
Y (5)
Y (7,5)
Y (5)
Y (5)
Y (5)
Y (5)
Y (5,8)
Y (5,9)
Y (5)
Y (5)
Y
Y (5,10)
Y (5)
Y (5)
Y
Y (5)
Y (5)
Y (5)
Y (5)
Y (5)
Y (11)
Y (5)
Y (5)
Y

N
N
N
N
Y
Y
N
N
N
Y
N
Y
N
Y
N
Y
Y
N
N
N
N
N
N
Y
Y
N
N
N
N
N

27
WPIDS / WPINDEX / WPIXDWPI Invention Level
SELECT, ANALYZE, and SORT Fields (cont’d)Field Name
Priority Year
Priority Year First
Priority Year, Basic
Publication Year
Publication Year, Basic
Ring Index Number
Ring Index Number, unlinked
Update Date
Update Date Cooperative Patent Classification
Update Date Enhanced Title
Update Date Index Term
Update Date International Patent Classification
Update Date Inventor
Update Date Japanese Patent Classification (F-terms, FI-terms)
Update Date Manual CodeUpdate Date Patent Assignee
Update Date Patent Family
Update Date Polymer Indexing
US National Patent Classification Current
US National Patent Classification, Current (main)
US National Patent Classification, Current (secondary)

Field Code
PRY
PRYF
PRY.B
PY
PY.B
RIN
RINU
UP
UPCP
UPTI
UPIT (UPKW)
UPIC
UPIN
UPFT
UPMC
UPPA
UPP
UPA
NCL
NCLM
NCLS

ANALYZE/
SELECT (1)
Y (5)
Y (5)
Y (5)
Y (5)
Y (5)
Y
Y
Y
N
N
Y
Y
Y
N
N
N
Y (5)
N
Y
Y
Y

SORT
Y
Y
N
Y
Y
N
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
N

(1) HIT may be used to restrict terms extracted to terms that match the search expression used to create the answer set, e.g., SEL HIT
TI.
(2) SELECTed, ANALYZed and SORTed application, priority and patent numbers are in the format set by the Messenger SET
PATENT command, either Derwent or STN.
(3) Selects or analyzes application and priority numbers and appends /APPS to the terms created by SELECT.
(4) Selects or analyzes DNC and DNN with /DN appended to the terms created by SELECT.
(5) SELECT HIT or ANALYZE HIT are not valid with this field.
(6) Appends /IPC.F to the terms created by SELECT.
(7) Selects or analyzes patent countries and designated states and appends /PCS to the terms created by SELECT.
(8) Selects or analyzes patent numbers with /PN appended to the terms created by SELECT.
(9) Selects or analyzes basic patent numbers with /PN.B appended to the terms created by SELECT.
(10) Selects or analyzes patent number and filing details and appends /PATS to the terms created by SELECT.
(11) Selects or analyzes priority numbers with /PRN appended to the terms created by SELECT.

February 2024

28
WPIDS / WPINDEX / WPIX

Additional DWPI Individual Patent Publication (often First Level Data)
SELECT, ANALYZE, and SORT Fields

Field Name
Agent
Agent Address
Agent, City
Agent, Country
Agent, Postal CodeAgent, State
Agent, Total
Application Information, Clarivate
Inventor Address
Inventor, City
Inventor, Country
Inventor, Nationality
Inventor, Original
Inventor, Postal CodeInventor, Residence
Inventor, State
Inventor, Total
IPC, Initial
IPC, Initial, Additional (supplementary)
IPC, Initial, Index (complementary)
IPC, Initial, Main
IPC, Initial, Secondary
Patent Assignee Address
Patent Assignee, City
Patent Assignee, Country
Patent Assignee, Limitation
Patent Assignee, Nationality
Patent Assignee, Original
Patent Assignee, Postal CodePatent Assignee, Residence
Patent Assignee, State
Patent Assignee, Total
Priority Application Information, Clarivate
Update Date Agent
Update Date Author Abstract
Update Date Author Title
Update Date Claims
US National Patent Classification, Issued
US National Patent Classification, Issued (main)
US National Patent Classification, Issued (secondary)

Field CodeAG
AGA
AG.CTY
AG.CNY
AG.ZIP
AG.ST
AG.T
APTS
INA
IN.CTY
IN.CNY
IN.NATINO
IN.ZIP
IN.RES
IN.ST
IN.T
IIC
IICA
IICI
IICM
IICS
PAA
PA.CTY
PA.CNY
PA.LIM
PA.NAT
PAO
PA.ZIP
PA.RES
PA.ST
PA.T
PRTS
UPAG
UPAA
UPAT
UPCL
INCL
INCLM
INCLS

ANALYZE/
SELECT (1)
Y
Y
Y (2)
Y (2)
Y (2)
Y (2)
Y
Y
Y
Y (2)
Y (2)
Y
Y
Y (2)
Y
Y (2)
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
N
N
N
Y
Y
Y

SORT
Y
N
N
N
N
N
N
N
N
N
N
N
Y
N
N
N
N
N
N
N
Y
N
N
N
N
N
N
Y
N
N
N
N
N
Y
Y
Y
Y
Y
N
N

(1) HIT may be used to restrict terms extracted to terms that match the search expression used to create the answer set, e.g. SEL HITINA.
(2) SELECT HIT or ANALYZE HIT are not valid with this field.

February 2024

29
WPIDS / WPINDEX / WPIX

Citation Data Fields
SELECT, ANALYZE, and SORT Fields

Field Name
Citation Category
Citation Category, Cited
Citation Category, Citing
Cited Accession Number
Cited Inventor
Cited Patent Assignee
Cited Patent Assignee Code
Cited Patent Assignee Code and Name
Cited Patent Country
Cited Patent Date
Cited Patent Kind Code
Cited Patent Number
Cited Patent Year
Citing Accession Number
Citing Inventor
Citing Patent Assignee
Citing Patent Assignee Code
Citing Patent Assignee Code and Name
Citing Patent Country
Citing Patent Date
Citing Patent Kind Code
Citing Patent Number
Citing Patent Year
Digital Object Identifier
Origin of Citation
Update Date, Cited
Update Date, Citing
XP Document Number

Field Code
CAT
CAT.D
CAT.G
AN.D
IN.D
PA.D
PACO.D
PAX.D
PC.D
PD.D
PK.D
PN.D
PY.D
AN.G
IN.G
PA.G
PACO.G
PAX.G
PC.G
PD.G
PK.G
PN.G
PY.G
DOI
ORC
UPD
UPG
XP

ANALYZE/
SELECT (1)
Y
Y
Y
Y
Y
Y (2)
Y (2)
Y
Y (2)
Y (2)
Y (2)
Y (2)
Y (2)
Y
Y
Y (2)
Y (2)
Y
Y (2)
Y (2)
Y (2)
Y (2)
Y (2)
Y (2)
Y
N
N
Y

SORT
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
Y
Y
N

(1) HIT may be used to restrict terms extracted to terms that match the search expression used to create the answer set, e.g. SEL HIT
PA.D.
(2) SELECT HIT or ANALYZE HIT are not valid with this field.

Citation Count Fields
SELECT, ANALYZE, and SORT Fields

Field Name
Cited DWPI Accession Number Count
Cited Literature Reference Count
Cited Patents Count
Cited Patents Country Count
Cited Reference Count (total)
Citing DWPI Accession Number Count
Citing Patents Count
Citing Patents Country Count

Field Code
ANC.D
CRC
PNC.D
PCC.D
REC
ANC.G
PNC.G
PCC.G

ANALYZE/
SELECT (1)
Y
Y
Y
Y
Y
Y
Y
Y

SORT
Y
Y
Y
Y
Y
Y
Y
Y

(1) HIT may be used to restrict terms extracted to terms that match the search expression used to create the answer set, e.g. SEL HIT
PNC.G

February 2024

30
WPIDS / WPINDEX / WPIX

Sample Records
DISPLAY IFULLGL1ANSWER 1 OF 1
ACCESSION NUMBER:
CROSS REFERENCE:

TITLE:

DERWENT CLASS:INVENTOR:PATENT ASSIGNEE:COUNTRY COUNT:WPIX COPYRIGHT 2024
CLARIVATE on STN
2018-08951P [201812]
WPIX Full-text
2018-08951J; 2018-08951L; 2018-08951M; 2018-08951N;
2018-08951Q; 2018-08991C; 2018-65567S; 2019-71222S;
2019-71222T; 2021-08476T; 2022-153370; 2023-315094
Transdermal delivery system for administering donepezilbase used for treating Alzheimer's disease, comprises
skin contact adhesive layer, and drug reservoir
comprising acrylate copolymer, glycerin and donepezilbase
A96; B03; B05; B07
JAIN A K; LEE E S; SAGI A; SINGH P(RIUM-C) CORIUM INC; (RIUM-C) CORIUM INT INC; (CORI-N)
CORIUM INT INC
135

PATENT INFORMATION:PATENT NO
KIND DATE
WEEK
LA PG
----------------------------------------------------------------US 20180028462 A1 20180201 (201812) * EN 24[5]AU 2017302306
A1 20190214 (201913)
EN
CA 3031945
A1 20180201 (201913)
EN
KR 2019034601
A 20190402 (201927)
KO
US 10300025
B2 20190528 (201940)
EN
CN 109789105
A 20190521 (201941)
ZH
EP 3490541
A2 20190605 (201942)
EN
JP 2019523268
T 20190822 (201964)
JA 34
KR 2406482
B1 20220608 (2022048) KO
KR 2022082928
A 20220617 (2022051) KO
JP 2022093707
A 20220623 (2022053) JA
JP 2022121629
A 20220819 (2022072) JA
JP 7153010
B2 20221013 (2022084) JA
CN 109789105
B 20221227 (2023003) ZH
JP 2019523270
T 20190822 (2023030) JA 37
WO 2018022817
A1 20180201 (2023030) EN
JP 7251033
B2 20230404 (2023031) JA
KR 2022082098
A 20220616 (2023052) KO
KR 2545643
B1 20230621 (2023052) KO
KR 2545649
B1 20230622 (2023052) KO
KR 2023097203
A 20230630 (2023054) KO
AU 2017302307
A1 20190214 (2023056) EN
AU 2023203616
A1 20230706 (2023056)# EN
AU 2023203618
A1 20230706 (2023056)# EN
WO 2018022816
A1 20180201 (2023056) EN
CN 109789106
A 20190521 (2023057) ZH
CN 116270551
A 20230623 (2023057) ZH
CN 109789106
B 20230627 (2023057) ZH
KR 2022082929
A 20220617 (2023058) KO
KR 2555208
B1 20230717 (2023058) KO
SG 11201900692 B 20230201 (2023062) EN
KR 2023109782
A 20230720 (2023064) KO
AU 2023204240
A1 20230727 (2023068)# EN
MX 2022006681
A1 20220711 (2023091) ES
CN 116966166
A 20231031 (2023093) ZH
February 2024

31
WPIDS / WPINDEX / WPIXAPPLICATION DETAILS:PATENT NOKINDAPPLICATIONDATE-----------------------------------------------------------------US 20180028462 A1
US 2017-15660939 20170726
US 20180028462 A1 Provisional
US 2017-504408P 20170510
US 20180028462 A1 Provisional
US 2017-504391P 20170510
US 20180028462 A1 Provisional
US 2017-457794P 20170210
US 20180028462 A1 Provisional
US 2017-444763P 20170110
US 20180028462 A1 Provisional
US 2017-444745P 20170110
US 20180028462 A1 Provisional
US 2016-423133P 20161116
US 20180028462 A1 Provisional
US 2016-367542P 20160727
US 20180028462 A1 Provisional
US 2016-367502P 20160727
US 10300025 B2 Provisional
US 2016-367502P 20160727
US 10300025 B2 Provisional
US 2016-367542P 20160727
US 10300025 B2 Provisional
US 2016-423133P 20161116
US 10300025 B2 Provisional
US 2017-444745P 20170110
US 10300025 B2 Provisional
US 2017-444763P 20170110
US 10300025 B2 Provisional
US 2017-457794P 20170210
US 10300025 B2 Provisional
US 2017-504391P 20170510
US 10300025 B2 Provisional
US 2017-504408P 20170510
AU 2023204240 A1 Div Ex
AU 2017-301928 20170726
AU 2017302306 A1
AU 2017-302306 20170726
AU 2023203618 A1 Div Ex
AU 2017-302306 20170726
AU 2017302307 A1
AU 2017-302307 20170726
AU 2023203616 A1 Div Ex
AU 2017-302307 20170726
CA 3031945 A1
CA 2017-3031945 20170726
CN 109789105 A
CN 2017-80059417 20170726
CN 109789105 B
CN 2017-80059417 20170726
CN 116270551 A Div Ex
CN 2017-80059417 20170726
CN 109789106 B
CN 2017-80059437 20170726
CN 109789106 A
CN 2017-80059437 20170726
CN 116966166 A Div Ex
CN 2017-80059437 20170726
EP 3490541 A2
EP 2017-749568 20170726
US 10300025 B2
US 2017-15660939 20170726
CA 3031945 A1 PCT Application
WO 2017-US44048 20170726
AU 2017302306 A1 PCT Application
WO 2017-US44048 20170726
KR 2019034601 A PCT Application
WO 2017-US44048 20170726
CN 109789105 A PCT Application
WO 2017-US44048 20170726
EP 3490541 A2 PCT Application
WO 2017-US44048 20170726
JP 2019523268 T PCT Application
WO 2017-US44048 20170726
KR 2406482 B1 PCT Application
WO 2017-US44048 20170726
KR 2022082928 A PCT Application
WO 2017-US44048 20170726
JP 7153010 B2 PCT Application
WO 2017-US44048 20170726
CN 109789105 B PCT Application
WO 2017-US44048 20170726
KR 2545649 B1 PCT Application
WO 2017-US44048 20170726
AU 2017302307 A1 PCT Application
WO 2017-US44049 20170726
WO 2018022816 A1
WO 2017-US44049 20170726
CN 109789106 B PCT Application
WO 2017-US44049 20170726
CN 109789106 A PCT Application
WO 2017-US44049 20170726
KR 2022082929 A PCT Application
WO 2017-US44049 20170726
KR 2555208 B1 PCT Application
WO 2017-US44049 20170726
KR 2023109782 A PCT Application
WO 2017-US44049 20170726
WO 2018022817 A1
WO 2017-US44050 20170726
JP 2019523270 T PCT Application
WO 2017-US44050 20170726
JP 7251033 B2 PCT Application
WO 2017-US44050 20170726
KR 2545643 B1 PCT Application
WO 2017-US44050 20170726
KR 2022082098 A PCT Application
WO 2017-US44050 20170726
KR 2023097203 A PCT Application
WO 2017-US44050 20170726
SG 11201900692 B PCT Application
WO 2017-US44050 20170726
February 2024

32
WPIDS / WPINDEX / WPIX
CA 3031945 A1 PCT Nat. Entry
CN 109789105 A PCT Nat. Entry
CN 109789105 B PCT Nat. Entry
CN 109789106 B PCT Nat. Entry
CN 109789106 A PCT Nat. Entry
JP 2019523268 T
JP 7153010 B2
JP 2022093707 A Div Ex
JP 2022121629 A Div Ex
JP 2019523270 T
JP 7251033 B2
KR 2545643 B1 Div Ex
KR 2022082098 A Div Ex
KR 2019034601 A
KR 2406482 B1
KR 2022082928 A Div Ex
KR 2545649 B1 Div Ex
KR 2022082929 A Div Ex
KR 2555208 B1 Div Ex
SG 11201900692 B
SG 11201900692 B PCT Nat. Entry
KR 2406482 B1 PCT Nat. Entry
CN 116270551 A
KR 2022082928 A
KR 2545649 B1
KR 2022082929 A
KR 2555208 B1
KR 2023109782 A Div Ex
KR 2545643 B1
KR 2022082098 A
KR 2023097203 A Div Ex
SG 11201900692 B Related to
MX 2022006681 A1
JP 2022093707 A
KR 2022082928 A PCT Nat. Entry
KR 2545649 B1 PCT Nat. Entry
KR 2022082929 A PCT Nat. Entry
KR 2555208 B1 PCT Nat. Entry
KR 2545643 B1 PCT Nat. Entry
KR 2022082098 A PCT Nat. Entry
JP 2022121629 A
CN 116966166 A
KR 2023097203 A
KR 2023109782 A
AU 2023203616 A1
AU 2023203618 A1
KR 2023097203 A PCT Nat. Entry
AU 2023204240 A1
KR 2023109782 A PCT Nat. Entry

CA 2017-3031945 20190124
CN 2017-80059417 20190326
CN 2017-80059417 20190326
CN 2017-80059437 20190326
CN 2017-80059437 20190326
JP 2019-503974 20170726
JP 2019-503974 20170726
JP 2019-504000 20170726
JP 2019-504001 20170726
JP 2019-504001 20170726
JP 2019-504001 20170726
KR 2019-7005331 20170726
KR 2019-7005331 20170726
KR 2019-7005737 20170726
KR 2019-7005737 20170726
KR 2019-7005737 20170726
KR 2019-7005737 20170726
KR 2019-7005739 20170726
KR 2019-7005739 20170726
SG 2019-11201900692 20170726
SG 2019-11201900692 20190125
KR 2019-7005737 20190226
CN 2022-11676624 20170726
KR 2022-7018732 20170726
KR 2022-7018732 20170726
KR 2022-7018748 20170726
KR 2022-7018748 20170726
KR 2022-7018748 20170726
KR 2022-7018749 20170726
KR 2022-7018749 20170726
KR 2022-7018749 20170726
SG 2022-10202260454 20170726
MX 2022-6681 20190125
JP 2022-76575 20220506
KR 2022-7018732 20220602
KR 2022-7018732 20220602
KR 2022-7018748 20220602
KR 2022-7018748 20220602
KR 2022-7018749 20220602
KR 2022-7018749 20220602
JP 2022-106083 20220630
CN 2023-10658352 20170726
KR 2023-7020235 20170726
KR 2023-7023326 20170726
AU 2023-203616 20230609
AU 2023-203618 20230609
KR 2023-7020235 20230615
AU 2023-204240 20230703
KR 2023-7023326 20230710

FILING DETAILS:PATENT NO
KIND
PATENT NO------------------------------------------------------CN 109789105 B
Previous Publ
CN 109789105 A
CN 109789106 B
Previous Publ
CN 109789106 A
JP 7153010 B2Previous Publ
JP 2019523268 T
JP 7251033 B2Previous Publ
JP 2019523270 T
US 10300025 B2Previous Publ
US 2018028462 A
February 2024

33
WPIDS / WPINDEX / WPIX
CA 3031945 A1
AU 2017302306 A1
KR 2019034601 A
CN 109789105 A
EP 3490541 A2
JP 2019523268 T
KR 2406482 B1
KR 2022082928 A
JP 7153010 B2
CN 109789105 B
KR 2545649 B1
AU 2017302307 A1
CN 109789106 B
CN 109789106 A
KR 2022082929 A
KR 2555208 B1
KR 2023109782 A
JP 2019523270 T
JP 7251033 B2
KR 2545643 B1
KR 2022082098 A
KR 2023097203 A
SG 11201900692 B

Based onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased onBased on

PRIORITY APPLN. INFO: US 2017-15660939
US 2017-504391P
US 2017-504408P
US 2017-457794P
US 2017-444745P
US 2017-444763P
US 2016-423133P
US 2016-367502P
US 2016-367542P
AU 2023-203616
AU 2023-203618
AU 2023-204240

WO 2018022815 A
WO 2018022815 A
WO 2018022815 A
WO 2018022815 A
WO 2018022815 A
WO 2018022815 A
WO 2018022815 A
WO 2018022815 A
WO 2018022815 A
WO 2018022815 A
WO 2018022815 A
WO 2018022816 A
WO 2018022816 A
WO 2018022816 A
WO 2018022816 A
WO 2018022816 A
WO 2018022816 A
WO 2018022817 A
WO 2018022817 A
WO 2018022817 A
WO 2018022817 A
WO 2018022817 A
WO 2018022817 A

20170726
20170510
20170510
20170210
2017011020170110
20161116
20160727
20160727
20230609
20230609
20230703

INT. PATENT CLASSIF.:
IPC RECLASSIF.:
A61K0031-00 [I,A]; A61K0031-045 [N,A]; A61K0031-13 [I,A];
A61K0031-137 [I,A]; A61K0031-18 [I,A]; A61K0031-19 [I,A];
A61K0031-192 [I,A]; A61K0031-196 [I,A]; A61K0031-27 [I,A]; A61K0031-445 [I,A]; A61K0031-663 [I,A]; A61K0047-02[I,A]; A61K0047-10 [I,A]; A61K0047-12 [I,A]; A61K0047-14[I,A]; A61K0047-20 [I,A]; A61K0047-26 [I,A]; A61K0047-32[I,A]; A61K0009-70 [I,A]; A61P0013-00 [I,A]; A61P0013-02[I,A]; A61P0013-08 [I,A]; A61P0025-00 [I,A]; A61P0025-04[I,A]; A61P0025-14 [I,A]; A61P0025-16 [I,A]; A61P0025-22[I,A]; A61P0025-24 [I,A]; A61P0025-26 [I,A]; A61P0025-28[I,A]; A61P0025-36 [I,A]; A61P0035-00 [I,A]; C08K0005-00
[I,A]
CPC:
A61K0031-00; A61K0031-045; A61K0031-13; A61K0031-137;
A61K0031-18; A61K0031-192; A61K0031-196; A61K0031-216;
A61K0031-27; A61K0031-381; A61K0031-4045; A61K0031-439;
A61K0031-445; A61K0031-4458; A61K0031-4468; A61K0047-02;
A61K0047-10; A61K0047-12; A61K0047-14; A61K0047-20;
A61K0047-32; A61K0009-7023; A61K0009-7038; A61K0009-7046;
A61K0009-7053; A61K0009-7061; A61K0009-7061;
A61K0009-7084; A61K0009-7084; A61K0009-7092; A61P0013-00;
A61P0013-02; A61P0013-08; A61P0025-00; A61P0025-02;
February 2024

34
WPIDS / WPINDEX / WPIX
A61P0025-04; A61P0025-14; A61P0025-16; A61P0025-22;
A61P0025-24; A61P0025-26; A61P0025-28; A61P0025-36;
A61P0029-00; A61P0035-00; C08K0005-0016
001001000

USCLASS NCLM:
JAP. PATENT CLASSIF.:
MAIN:
A61K0009-70 401
SECONDARY:
A61K0031-13; A61K0031-137; A61K0031-18; A61K0031-19;
A61K0031-192; A61K0031-196; A61K0031-27; A61K0031-445;
A61K0031-663; A61K0047-02; A61K0047-10; A61K0047-14;
A61K0047-20; A61K0047-26; A61K0047-32; A61P0013-00;
A61P0013-08; A61P0025-14; A61P0025-16; A61P0025-22;
A61P0025-24; A61P0025-26; A61P0025-28; A61P0025-36
FTERM CLASSIF.:
4C076; 4C086; 4C206; 4C086/AA01; 4C206/AA01; 4C086/AA02;
4C206/AA02; 4C076/AA72; 4C076/AA81; 4C076/BB31;
4C086/BC21; 4C076/CC01; 4C086/DA02; 4C206/DA22;
4C206/DA25; 4C206/DA30; 4C086/DA34; 4C076/DD37;
4C076/DD38; 4C076/DD44; 4C076/DD47; 4C076/DD48;
4C076/DD55; 4C076/EE03; 4C076/EE13; 4C076/EE27;
4C076/EE49; 4C206/FA10; 4C206/FA29; 4C206/FA31;
4C076/FF68; 4C206/HA24; 4C206/JA13; 4C206/KA01;
4C206/KA04; 4C206/KA09; 4C086/MA01; 4C206/MA01;
4C086/MA05; 4C086/MA63; 4C206/MA83; 4C086/NA14;
4C086/ZA01; 4C206/ZA01; 4C086/ZA11; 4C206/ZA11;
4C086/ZA12; 4C206/ZA12; 4C086/ZA16; 4C206/ZA16;
4C086/ZA81; 4C206/ZA81
GRAPHIC IMAGE:

BASIC ABSTRACT:US 20180028462 A1
UPAB 20180222
NOVELTY - A transdermal delivery system comprises a skin contact
adhesive layer (14) for attaching to skin of user, and a drug reservoir(12) comprising acrylate copolymer, glycerin and donepezil base generated
in-situ by reaction of donepezil hydrochloride and alkaline salt.
DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for acomposition comprising drug reservoir which contains donepezil base,glycerin, and acrylic acid/vinyl acetate copolymer; or drug reservoir whichcontains donepezil base, solvent comprising triethyl citrate, lauryllactate, sorbitan monolaurate and/or glycerin, and crosslinked
polyvinylpyrrolidone and acrylic acid/vinyl acetate copolymer.
ACTIVITY - Neuroprotective; Nootropic. Test details are described but
no results given.
MECHANISM OF ACTION - Acetylcholinesterase Inhibitor.
USE - Transdermal delivery system for administering donepezil baseused for treating Alzheimer's disease in subject (claimed).

February 2024

35
WPIDS / WPINDEX / WPIXADVANTAGE - The system achieves transdermal delivery of therapeutic
agent at steady state that is bioequivalent to oral administration oftherapeutic agent.
DESCRIPTION OF DRAWINGS - The drawing shows a sectional view oftransdermal delivery system.
Drug reservoir (12)Skin contact adhesive layer (14)Microporous membrane (16)
Backing layer (18)
Release liner (20)TECHNOLOGY FOCUS:
INORGANIC CHEMISTRY - Preferred Components: The alkaline salt in
the drug reservoir layer is sodium carbonate, potassium carbonate,trisodium phosphate, disodium hydrogen phosphate, or preferably sodium
bicarbonate.
ORGANIC CHEMISTRY - Preferred Components: The intermediate layer isa microporous membrane (16). The pores in microporous membrane containsolvent composition comprising triethyl citrate, sorbitan monolaurate,
and/or lauryl lactate. The drug reservoir layer further comprises
triethyl citrate and sorbitan monolaurate and/or lauryl lactate. The
alkaline salt may be sodium oxalate, sodium succinate, sodium citrate,and sodium salicylate.
PHARMACEUTICALS - Preferred Components: The delivery system further
comprises an intermediate layer disposed between contact adhesive layerand drug reservoir, a first backing layer in contact with the drug
reservoir layer, an adhesive overlay in contact with the first backing
layer, and a second backing layer in contact with the adhesive overlay.
The drug reservoir comprises donepezil base generated in situ by reactionof 5-25 weight%, preferably 10-18 weight% donepezil hydrochloride and 1-5
weight% sodium bicarbonate; 0-15 weight%, preferably 8-12 weight% triethyl
citrate; 0-5 weight%, preferably 1.5-2.5 weight% sorbitan monolaurate; 515 weight%, preferably 9-11 weight% glycerin; 1-10 weight% lauryl lactate;
5-25 weight%, preferably 13-17 weight% crosslinked polyvinylpyrrolidone;and 30-65 weight%, preferably 40-42 weight% acrylate-vinyl acetate
copolymer.
POLYMERS - Preferred Components: The skin contact adhesive layer
comprises acrylic acid/vinyl acetate copolymer, crosslinked
polyvinylpyrrolidone, and solvent composition. The skin contact adhesive
layer is manufactured from adhesive formulation that does not containdonepezil base or donepezil salt. The microporous membrane ispolypropylene membrane. The adhesive overlay is a single layer ofacrylate copolymer or comprises a first layer comprising polyisobutylene
and polybutene, and a second layer comprising acrylic adhesive.
EXTENSION ABSTRACT:ADMINISTRATION - The transdermal delivery system is administeredonce weekly and provides donepezil base at 1-25 mg/24 hours (claimed).
EXAMPLE - 1.20 g Sorbitan monolaurate was dissolved in 6 g triethyl
citrate and mixed with 1.80 g lauryl lactate and 89.69 g ethyl acetate. 6 g
Glycerin was added and mixed. 9 g Donepezil hydrochloride and 1.82 g
sodium bicarbonate were added and dispersed in the mixture. 12 g
Crosslinked micronized polyvinylpyrrolidone was added and the mixture washomogenized. 43.93 g Acrylic acid/vinyl acetate copolymer was added andmixed. The wet adhesive formulation was coated on release liner and driedto yield dry coating weight of 12 mg/cm2 to obtain drug reservoir. 0.60 g
Sorbitan monolaurate was dissolved in 3 g triethyl citrate and mixed with
0.9 g lauryl lactate, 25.45 g ethyl acetate and 1.34 g isopropanol. 6 g
Crosslinked, micronized polyvinylpyrrolidone was added and the mixture
was homogenized. 38.61 g Acrylic acid/vinyl acetate copolymer was added
and mixed. The wet adhesive formulation was coated on a release liner anddried to obtain dry coating weight of 5 mg/cm2 to obtain contact
adhesive. A rate controlling membrane was laminated on adhesive side ofFebruary 2024

36
WPIDS / WPINDEX / WPIX
drug reservoir. The contact adhesive was laminated on top of rate
controlling membrane. The release liner on drug reservoir side was
replaced and laminated with backing film. The final five layer laminate
was die-cut into transdermal patches.
FILE SEGMENT: CPI
MANUAL CODE:
CPI: A04-D05A; A04-F04B; A04-F06E5; A04-F09; A12-V01; B04-C03;
B05-A01A; B05-A01B; B05-B02A3; B07-A02A; B07-D05; B10-C02;
B10-C03; B10-E04C; B10-G02; B12-M02D; B12-M02F; B14-D07A;
B14-J01A4DISPLAY MEMBMember(0001)
PI
US 20180028462 A1 20180201 (201812) * EN 24[5]TIEN DONEPEZIL TRANSDERMAL DELIVERY SYSTEMINLEE E S
INO: Lee, Eun Soo
INA: Redwood City, CA, US
JAIN A K
INO: Jain, Amit K.
INA: Milpitas, CA, US
SINGH P
INO: Singh, Parminder
INA: Union City, CA, US
PA(CORI-N) CORIUM INT INC
PAO: CORIUM INTERNATIONAL, INC.
PAA: Menlo Park, CA, US
Residence: US
Nationality: US
ADT US 20180028462 A1 US 2017-15660939 20170726; US 20180028462 A1 Provisional
US 2017-504408P 20170510; US 20180028462 A1 Provisional US 2017-504391P
20170510; US 20180028462 A1 Provisional US 2017-457794P 20170210; US
20180028462 A1 Provisional US 2017-444763P 20170110; US 20180028462 A1
Provisional US 2017-444745P 20170110; US 20180028462 A1 Provisional US
2016-423133P 20161116; US 20180028462 A1 Provisional US 2016-367542P
20160727; US 20180028462 A1 Provisional US 2016-367502P 20160727
APTS 2017US-000660939 20170726; 2017US-000504408P 20170510; 2017US-000504391P
20170510; 2017US-000457794P 20170210; 2017US-000444763P 20170110;
2017US-000444745P 20170110; 2016US-000423133P 20161116; 2016US-000367542P
20160727; 2016US-000367502P 20160727
IPCI Current: A61K0009-70 [I,A]
Original: A61K0009-70 [I,A]
CPC Current: A61K0031-00; A61K0031-045; A61K0031-13; A61K0031-137;
A61K0031-18; A61K0031-27; A61K0031-445; A61K0047-02; A61K0047-10;
A61K0047-12; A61K0047-32; A61K0009-7023; A61K0009-7038; A61K0009-7053;
A61K0009-7061; A61K0009-7084; A61K0009-7092; C08K0005-0016
Original: A61K0031-445; A61K0009-7038; A61K0009-7084
NCL NCLM 001/001.000
ABEN A transdermal delivery system for systemic delivery of donepezil is
described, where the system comprises an adhesive matrix drug reservoir
layer comprised of a copolymer of acrylic acid/vinyl acetate, triethyl
citrate, and donepezil base generated in situ by reaction of donepezil HCl
and an alkaline salt. The system is provided for treatment of Alzheimer's
disease, and achieves transdermal delivery of the therapeutic agent at
steady state that is bioequivalent to administration of the therapeutic
agent orally.
CLMEN [CLAIM 1] 1. A transdermal delivery system for systemic delivery of
donepezil, comprising:a skin contact adhesive layer to attach the system
to the skin of a user, anda drug reservoir comprised of (i) an acrylate
copolymer, (ii)glycerin, and (iii) donepezil base generated in situ by
February 2024

37
WPIDS / WPINDEX / WPIX
reaction of donepezil HCl and an alkaline salt.
[CLAIM 2] 2. The system of claim 1, further comprising an intermediate
layer directly on the contact adhesive layer and disposed between thecontact adhesive layer and the drug reservoir.
[CLAIM 3] 3. The system of claim 2, wherein the intermediate layer is a
microporous membrane comprising a plurality of pores.
[CLAIM 4] 4. The system of claim 3, wherein the plurality of pores in the
microporous membrane contains a solvent composition comprised of one ormore of triethyl citrate, sorbitan monolaurate, and lauryl lactate.
[CLAIM 5] 5. The system of claim 1, wherein the skin contact adhesive
layer is comprised of a copolymer of acrylic acid/vinyl acetate.
[CLAIM 6] 6. The system of claim 5, wherein the skin contact adhesive
layer additionally comprises crosslinked polyvinylpyrrolidone.
[CLAIM 7] 7. The system of claim 1, wherein the skin contact adhesive
layer comprises a solvent composition comprising one or more solvents
selected from the group consisting of triethyl citrate, sorbitanmonolaurate, and lauryl lactate.
[CLAIM 8] 8. The system of claim 1, wherein the skin contact adhesive
layer is manufactured from an adhesive formulation that does not comprise
donepezil base or a donepezil salt.
[CLAIM 9] 9. The system of claim 1, wherein the alkaline salt in the drug
reservoir layer is sodium bicarbonate.
[CLAIM 10] 10. The system of claim 1, the drug reservoir layer
additionally comprises triethyl citrate.
[CLAIM 11] 11. The system of claim 10, wherein the drug reservoir layer
additionally comprises one or both of sorbitan monolaurate and lauryllactate.
[CLAIM 12] 12. The system of claim 1, further comprising a first backing
layer in contact with the drug reservoir layer, an adhesive overlay incontact with the first backing layer; and a second backing layer incontact with the adhesive overlay.
[CLAIM 13] 13. The system of claim 12, wherein the adhesive overlay issingle layer comprised of an acrylate copolymer.
[CLAIM 14] 14. The system of claim 13, wherein the adhesive overlayer iscomprised of a first layer and a second layer, the first layer composedof a polyisobutylene and polybutene and the second layer composed of anacrylic adhesive.
[CLAIM 15] 15. A composition, comprising:a drug reservoir comprising (i)donepezil base generated in situ by reaction of donepezil HCl and an
alkaline salt; (ii) glycerine; and (iii) a copolymer of acrylic
acid/vinyl acetate.
[CLAIM 16] 16. The composition of claim 15, wherein the drug reservoir
further comprises triethyl citrate or sorbitan monolaurate.
[CLAIM 17] 17. The composition of claim 15, wherein the drug reservoir
comprises an acrylic acid/vinyl acetate copolymer adhesive and acrosslinked polyvinylpyrrolidone.
[CLAIM 18] 18. The composition of claim 15, wherein the alkaline salt isselected from the group consisting of sodium carbonate, sodium
bicarbonate, potassium carbonate, potassium bicarbonate, trisodium
phosphate, disodium hydrogen phosphate, sodium oxylate, sodium succinate,sodium citrate, and sodium salicylate.
[CLAIM 19] 19. A composition, comprising:a drug reservoir consisting
essentially of donepezil base generated in situ by reaction of donepezil
HCl and sodium bicarbonate; a solvent composition comprising one or moreof triethyl citrate, lauryl lactate, sorbitan monolaurate, and glycerin;crosslinked polyvinylpyrrolidone and a copolymer of acrylic acid/vinyl
acetate.
[CLAIM 20] 20. A composition, comprising:a drug reservoir consisting
essentially of:(a) donepezil base generated in situ by reaction of
between about 5-25 wt % donepezil HCl and between about 1-5 wt % sodium
bicarbonate;(b) about 0-15 wt % triethyl citrate;(c) about 0-5 wt %February 2024

38
WPIDS / WPINDEX / WPIX
sorbitan monolaurate(d) about 5-15 wt % glycerin;(e) about 1-10 wt %lauryl lactate;(f) about 5-25 wt % crosslinked polyvinylpyrrolidone;
and(g) about 30-65 wt % acrylate-vinylacetate copolymer.
[CLAIM 21] 21. A composition, comprising:a drug reservoir consisting
essentially of:(a) donepezil base generated in situ by reaction of
between about 10-18 wt % donepezil HCl and between about 1-5 wt % sodium
bicarbonate;(b) about 8-12 wt % triethyl citrate;(c) about 1.5-2.5 wt %sorbitan monolaurate(d) about 9-11 wt % glycerin;(e) about 1-10 wt %lauryl lactate;(f) about 13-17 wt % crosslinked polyvinylpyrrolidone;
and(g) about 40-42 wt % acrylate-vinylacetate copolymer.
[CLAIM 22] 22. A composition, comprising:(a) a drug reservoir comprisedof the composition of claim 15;(b) a microporous membrane or a non-wovenlayer; and(c) a skin contact adhesive.
[CLAIM 23] 23. The composition according to claim 22, wherein the
microporous membrane is a polypropylene membrane.
[CLAIM 24] 24. The composition of claim 22, wherein the composition
comprises a microporous membrane with a plurality of pores, the pluralityof pores contain a solvent composition comprised of one or more oftriethyl citrate, sorbitan monolaurate, and lauryl lactate.
[CLAIM 25] 25. A method for delivering donepezil base to a subject,comprising:providing a transdermal delivery system according to claim 1,
andadministering or instructing to administer the transdermal delivery
system to the skin of a subject.
[CLAIM 26] 26. The method of claim 25, wherein the method is fortreatment of a subject with Alzheimer's disease.
[CLAIM 27] 27. The method of claim 26, wherein the administering or
instructing to administer comprises administering or instructing toadminister once weekly.
[CLAIM 28] 28. The method of claim 25, wherein the transdermal delivery
system comprises a dose of donepezil base to provide between 1-25 mg/24
hours.
Member(0002)
ooooooooooo

February 2024

39
WPIDS / WPINDEX / WPIXDISPLAY CITN (full citation information)AN2018-58265Y [201854]

WPIX

Citation Counters----------------PNC.D
23
Cited Patents Count
PCC.D
3
Cited Patents Country Count
CRC
16
Cited Literature Reference Count
REC
39
Cited Reference Count (total)
ANC.D
23
Cited DWPI Accession Number Count
PNC.G
3
Citing Patents Count
PCC.G
2
Citing Patents Country Count
ANC.G
2
Citing DWPI Accession Number CountEXF Examiner's Field of Search------------------------------Citing Publication
EXF Examiner's Field of Search---------------------------------------------------US 10898617 B2

CPC

A61L2300-404; A61L2300-42; A61L2400-18;
A61L2420-02; A61L0029-041; A61L0029-043;
A61L0029-06; A61L0029-16; A61L0031-042;
A61L0031-046; A61L0031-06; A61L0031-16

CDP Cited Patents-----------------Citing Publication By
Cat
Cited Patent
Date
Accession Number-------------------------------------------------------------------------------US 20180207323 A1
EYUS 20050107870 A1
20050519 2005-402993
PA: (GREE-I) GREENWALD H J; (WANG-I) WANG X
IN: GREENWALD H J; WANG X
Relevant passages: [0059]
Relevant to claim: 5
E
X
US 20120136323 A1
20120531 2011-B93445
PA: (NOVA-N) NOVAN INC
IN: BAUMAN S; JOSHI P R; STASKO N
Relevant passages: abstract Fig. 1, [0117], [0137] |[0059] | claim 3 | F.2d | [0063] and [0064] |[0081] | [0079]-[0080] | [0088] | claim 9 | [0125]| claim 13 | claim 14 | [0145] | claim 24 | claim
15 | [0100] and [0113] | claim 19 | [0147] | [0155]| claim 22 | [0058], [0059], [0063] [0064] | para
[0058] | claim 5 | claim 1 | Fig. 4B Fig 5B [0138]| [0141] | column 4 lines 47-51 | column 5 lines
7-10 | claim 18 | , abstract Fig. 1, [0117], [0137]| [0059] | claim 3 | F.2d | [0063] and [0064] |[0081] | [0079]-[0080] | [0088] | claim 9 | [0125]| claim 13 | claim 14 | [0145] | claim 24 | claim
15 | [0100] and [0113] | claim 19 | [0147] | [0155]| claim 22 | [0058], [0059], [0063] [0064] | para
[0058] | claim 5 | claim 1 | Fig. 4B Fig 5B [0138]| [0141] | column 4 lines 47-51 | column 5 lines
7-10 | claim 18 |Relevant to claim: 1-4, 6-15, 19, 22 , 5, 16-18
E
Y
US 7750201 B2
20100706 2008-E59466
PA: (COVI-C) TYCO HEALTHCARE GROUP LP
IN: DOWD B; FINK E D; HEAGLE D G; MULLIGAN S A; ORR S;
PATEL H A; SHAH C B; SWANIKER H P; TRANCHEMONTAGNE
February 2024

40
WPIDS / WPINDEX / WPIXWO 2018136845 A1

E

E

E

EP 3570927 A4

E

E

E

A; VITARIS R F; WARD K
Relevant passages: abstract Fig. 2 | column 5 line 53
column 6 line 5 | column 4 lines 47-51 | column 5lines 7-10 | claim 18 | claim 19 | [0059]
Relevant to claim: 16-18
Y
RU 2350356 C1
20090327 2009-G41921
PA: (CHAS-I) CHASHCHIN V A; (KHOT-I) KHOTIMSKII D V;
(MANA-I) MANAEVA T V; (VISH-I) VISHNYAKOV A V
IN: CHASHCHIN V A; KHOTIMSKII D V; MANAEVA T V;
VISHNYAKOV A V
Relevant passages: , abstract, pp.5-6, examples
Relevant to claim: 21
Y
US 20050107870 A1
20050519 2005-402993
PA: (GREE-I) GREENWALD H J; (WANG-I) WANG X
IN: GREENWALD H J; WANG X
Relevant passages: , paragraphs [0274], [0282], [0298]
Relevant to claim: 11, 16-18
A
US 20150297782 A1
20151022 2010-E89227
PA: (MILL-I) MILLER C; (MURR-I) MURRAY B
IN: MILLER C; MURRAY B
Relevant to claim: 1-21
X
US 20110244001 A1
20111006 2011-M58027
PA: (UYSR-C) UNIV SYRACUSE
IN: ISHIDA K; MATHER P; ONYEJEWKE I
Relevant passages: claim 1, 5 ; fig. 1, 4, 6 ; para 09,
35, 28, 70
Relevant to claim: 1-5,7,14
IX
WO 2006084912 A1
20060817 2006-578124
PA: (NOLA-N) NOLABS AB
IN: PETERS T; PETERS, Tor
Relevant passages: claim 1 ; fig. 1B ; pp. 14, line 26,
pp. 15, line 15 ; pp. 21, line 15-28
Relevant to claim: 1-5,7,10,14|12,13,15
X
WO 2016201237 A1
20161215 2016-77058H
PA: (UNMI-C) UNIV MICHIGAN
IN: LAUTNER G; MEYERHOFF M E; SCHWENDEMAN S P
Relevant passages: claim 1, 2, 5, 16 ; fig. 1, 4 ; para
42, 43 ; para 50, 56 ; pp. 29
Relevant to claim: 1,4,5,8-11,14

oooooooooooo
CDL Literature Citations------------------------Citing Publication
By
Cat
Literature Reference-------------------------------------------------------------------------------WO 2018136845 A1
E
XY
HANDA H. ET AL.: "In vitro and in vivo studyof sustained nitric oxide release coating
using diazeniumdiolate-oped poly(vinyl
chloride) matrix with poly(lactide-coglycolide) additive", J MATER CHEM B MATER
BIOL MED., vol. 1, no. 29, 7 August 2013(2013-08-07), pages 3578 - 3587,
XP055519460,relevantClaims[1, 2, 4-8, 10, 12,
13, 19, 20|3, 9, 11, 14-18],relevantPassages[,
especially abstract, pp. 1-9, fig. 1, 2]
E
Y
HARVEY A. LIU ET AL.: "Novel Delivery System
for the Bioregulatory Agent Nitric Oxide",
CHEMISTRY OF MATERIALS, vol. 21, no. 21,
November 2009 (2009-11-01), pages 5032 - 5041,
February 2024

41
WPIDS / WPINDEX / WPIX

EP 3570927 A4

E

Y

E

Y

E

Y

E

X

E

XP055519461,relevantClaims[14,21],relevantPassages[, especially p.5034, col.
1]
ROBB WL: "Thin silicone membranes-theirpermeation properties and some applications",
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES,
vol. 146, no. 1, 1968, pages 119 - 137,
XP055519463,relevantClaims[3],relevantPassages[, especially p.125, Table 1]
JUN YANG: "Potential anti-thrombotic nitricoxide generating layer-by-layer assembly", A
DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT
OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR
OF PHILOSOPHY (CHEMISTRY) IN THE UNIVERSITY OF
MICHIGAN, 2010, pages 1 - 157,
XP055519465,relevantClaims[9]GOUDIE J. MARCUS ET AL.: "Characterization ofan S-nitroso-N-acetylpenicillamine- based
nitric oxide releasing polymer from atranslational perspective", INT J POLYM MATER.
AND POLYM BIOMATERIALS, vol. 65, no. 15, 15
June 2016 (2016-06-15), pages 769 - 778,
XP055519472,relevantClaims[15],relevantPassage
s[especially pp. 771, 772, ???. 1]
ELIZABETH J. BRISBOIS ET AL: "Improved
Hemocompatibility of Multilumen Catheters via
Nitric Oxide (NO) Release from S -Nitroso- N-acetylpenicillamine (SNAP) Composite Filled
Lumen", ACS APPLIED MATERIALS & INTERFACES,
vol. 8, no. 43, 21 October 2016 (2016-10-21),
US, pages 29270 - 29279, XP055748916, ISSN:
1944-8244, DOI:
10.1021/acsami.6b08707,relevantClaims[1,4-6,8,14],relevantPassages[pp. 29271, col. 1, |fig.
1, 3, |pp. 29273, para 3.1, ]DOI: https://doi.org/10.1021/acsami.6b08707
See also references of WO 2018136845A1

ooooooooooooo
CGP Citing Patents------------------Cited Publication
By
Cat
Citing Patent
Date
Accession Number------------------------------------------------------------------------------US 20180207323 A1
EA
CN 109575246 A
20190405 2019-33484A
PA: (UYSJ-C) UNIV SOUTHWEST JIAOTONG
IN: HE J; TANG P; YANG H; ZHENG X
E
XY
WO 2021040813 A1
20210304 2021-195944
PA: (NOTA-N) NOTA LAB LLC
IN: KAHN M; MARTIN G; MEYERHOFF M E
EYWO 2021040814 A1
20210304 2021-195944
PA: (NOTA-N) NOTA LAB LLC
IN: KAHN M; MARTIN G; MEYERHOFF M E

February 2024

42
WPIDS / WPINDEX / WPIXDISPLAY HITSTR after structure search in DCR and crossover to DWPIAN.S DCR-96154
CN.P GLICLAZIDEMF
C15 H21 N3 O3 S
STRAN.S DCR-109127
CN.P TOLAZAMIDEMF
C14 H21 N3 O3 S
STRIn North America

In Europe

In Japan

CAS Customer Center:
P.O. Box 3012
Columbus, Ohio 43210-0012
U.S.A.

CAS Customer Center EMEA
represented by
FIZ Karlsruhe - Leibniz-Institute for Information Infrastructure
Hermann-von-Helmholtz-Platz 176344 Eggenstein-Leopoldshafen
Germany

JAICI(Japan Association for International Chemical Information)
Nakai Building
6-25-4 Honkomagome, Bunkyo-ku
Tokyo 113-0021
Japan

Phone:

Phone:
E-mail:Internet:

Phone:

E-mail:Internet:

800-753-4227 (North America)
614-447-3731 (worldwide)
help@cas.org
www.cas.org+49-721-9588 3155
EMEAhelp@cas.org
www.fiz-karlsruhe.deE-mail:Internet:February 2024

+81-3-5978-3601 (Technical Service)+81-3-5978-3621 (Customer Service)support@jaici.or.jp (Technical Service)customer@jaici.or.jp (Customer Service)www.jaici.or.jp